SlideShare ist ein Scribd-Unternehmen logo
1 von 10
Downloaden Sie, um offline zu lesen
Oral Diseases (2007) 13, 376–385. doi:10.1111/j.1601-0825.2006.01291.x
       Ó 2007 The Authors. Journal compilation Ó 2007 Blackwell Munksgaard
                                                          All rights reserved
                                         http://www.blackwellmunksgaard.com


ORIGINAL ARTICLE

Anti-inflammatory effects of Lactobacillus brevis (CD2) on
periodontal disease
DN Della Riccia1, F Bizzini1, MG Perilli2, A Polimeni3, V Trinchieri4, G Amicosante2 and MG Cifone1
1
 Department of Experimental Medicine, University of L’Aquila, L’Aquila, Italy; 2Department of Biomedical Sciences and
Technologies, University of L’Aquila, L’Aquila, Italy; 3Department of Odontostomatologic Sciences, University ÔLa Sapienza’, Rome,
Italy; 4Department of Infectious and Tropical Diseases, University ÔLa Sapienza’, Rome, Italy




OBJECTIVES: To analyze the anti-inflammatory effects                             Introduction
of Lactobacillus brevis extracts on periodontitis patients
and to investigate the involved mechanisms in vitro on                          Lactic acid bacteria (LAB) belong to a variety of genera
activated macrophages.                                                          used for milk fermentation. The primary metabolic end
METHODS: Eight healthy subjects and 21 patients with                            product from carbohydrate metabolism is lactic acid,
chronic periodontitis were enrolled to analyze the effect                       which in turn preserves milk by providing the acidity
of L. brevis-containing lozenges on periodontitis-associ-                       necessary for a tart flavor and for changes in the
ated symptoms and signs. Before and after the treat-                            structure of casein to achieve syneresis and desired
ment, the patients received a complete periodontal                              functional characteristics. The extensive knowledge on
examination. Saliva samples, collected before and after                         LAB has opened new possibilities for their application
treatment, were analyzed for metalloproteinase and ni-                          (for reviews see Konings et al, 2000; Caglar et al, 2005).
                                                                                                                         ¸
tric oxide synthase (NOS) activity, immunoglobulin-A                            Reports of many investigators have confirmed that LAB
(IgA), prostaglandin E2 (PGE2) and c-interferon (IFN-c)                         and their products have beneficial effects on the health
levels. Arginine deiminase (AD) and NOS activities were                         of animals and humans, i.e., protection against enteric
determined through a radiometric assay. Metallopro-                             infections, use as an oral adjuvant, immunopotentiation
teinases were assayed by zymogram and Western blot-                             in malnutrition, and prevention of chemically induced
ting, whereas IgA, PGE2 and IFN-c were assayed by                               tumors (Bodana and Rao, 1990; Roberfroid, 1998;
enzyme-linked imunosorbent assay tests.                                         Dugas et al, 1999; Gorbach, 2000). Almost all genera of
RESULTS: The treatment led to the total disappearance                           LAB are able to produce bacteriocins that are primarily
or amelioration of all analyzed clinical parameters in all                      lethal to other strains and species of bacteria form short-
patients. This was paralleled to a significant decrease of                       lived pores in biologic membranes by interactions with
nitrite/nitrate, PGE2, matrix metalloproteinase, and IFN-                       different compounds including nisin, lipid II and
c levels in saliva samples.                                                     phospholipids, thereby killing the target bacteria (Kon-
CONCLUSION: Our results suggest that the anti-                                  ings et al, 2000). In the attempt to better characterize the
inflammatory effects of L. brevis could be attributed to                         metabolic features of some LAB strains, our group has
the presence of AD which prevented nitric oxide gen-                            recently shown the presence of high levels of arginine
eration. Our findings give further insights into the                             deiminase (AD) in Lactobacillus brevis (Di Marzio et al,
knowledge of the molecular basis of periodontitis and                           2001). As bacterial AD may compete with nitric oxide
have a potential clinical significance, giving the experi-                       synthase (NOS) by using the same substrate, arginine,
mental ground for a new innovative, simple and effica-                           we decided to investigate the ability of L. brevis extracts
cious therapeutical approach of periodontal disease.                            to inhibit NOS activity as well other inflammatory
Oral Diseases (2007) 13, 376–385                                                parameters [c-interferon (IFN-c), prostaglandin E2
                                                                                (PGE2) and metalloproteinases], known to be associated
Keywords: L. brevis; nitric oxide; metalloproteinases; prostaglan-              with NOS induction (Cifone et al, 1999; Goodwin et al,
din E2; c-interferon                                                            1999; Di Marzio et al, 2001; Ishii et al, 2003). In
                                                                                particular, the chronic periodontal disease was chosen
                                                                                as the known inflammatory model to test the potential
Corresponding Author: Dr MG Cifone, Department of Experimental                  in vivo anti-inflammatory effects of L. brevis.
Medicine, University of L’Aquila, Via Vetoio, 10, Coppito 2, 67100                 Periodontal disease is a major cause of tooth loss in
L’Aquila, Italy. Tel: 0862 433503, Fax: 0862 433523, E-mail: pres-              humans and is one of the most prevalent diseases
med@cc.univaq.it                                                                associated with bone loss. Following bacterial coloniza-
Received 19 November 2006; revised 9 January 2006; accepted 30
January 2006                                                                    tion, the gingiva becomes inflamed leading, in some cases,
Anti-inflammatory effects of L. brevis
                                                              DN Della Riccia et al

                                                                                                                             377
to the destruction of the alveolar bone. Periodontitis has    (Centricon 10) from Amicon (Amicon, Millipore Co.,
two distinct but interconnected etiologic components:         Bedford, MA, USA). IFN-c (Endogen, Inc., Walburn,
periodontopathic bacteria adjacent to the periodontal         MA, USA) and PGE2 Elisa kits (Assay Designs Inc.,
tissues, and host-mediated connective tissue-destructive      Ann Arbor, MI, USA) were purchased from TEMA
responses to the causative bacteria and their metabolic       ricerca srl (Bologna, Italy). IgAs Elisa kits were
products (Golub et al, 1998). Treatment strategies            obtained from IPR (Catania, Italy).
against periodontal diseases have evolved with the aim
of eliminating specific pathogens or suppressing destruc-      Preparation of bacterial extracts
tive host response. Although the pathogenesis of the          Lactobacillus brevis, obtained from VSL Pharmaceuti-
various forms of this disease is not completely under-        cals (Gaithersburg, MD, USA) in a pure lyophilized
stood, several factors are believed to play an important      form (108 colony-forming units per gram), was routinely
role, including inflammatory cytokines (McGee et al,           grown in MRS broth medium under aerobic conditions.
1998; Graves, 1999), PGE2 (Offenbacher, 1996; Tsai et al,      For the determination of AD activity and for in vitro
1998; Kornman, 1999), nitric oxide (Matejka et al, 1999;      experiments on macrophages, L. brevis cultures were
Takeichi et al, 2000) and salivary immunoglobulin-A           washed and resuspended in 10 ml phosphate-buffered
(IgA) antibodies (Schenk et al, 1993). Moreover, many of      solution (PBS), sonicated (30 min, alternating 10 s
the characteristics of periodontal diseases such as inflam-    sonication and 10 s pause) with a Vibracell sonicator
mation and attachment loss are associated with proteo-        (Sonic and Materials Inc., Danbury, CT, USA), centri-
lytic events. Indeed, oral damage can result from the         fuged at 7500 g for 20 min at 4°C and the supernatants
release of an array of proteolytic enzymes by colonizing      stored at )20°C until used (bacterial extract). For
bacteria as well as host-derived proteases (Henskens et al,   the in vitro experiments, the bacterial extract was
1996; Baron et al, 1999; Korostoff et al, 2000; Travis and     added to cell cultures at 0.5 mg/105cells/1 ml)1 (final
Potemba, 2000). Selection of an appropriate delivery          concentration).
system is an important factor and, periodontitis being a         For gene expression studies, genomic DNA was
Ôlocalized’ disease condition, local drug treatment should    isolated from an overnight culture of L. brevis using
be preferred.                                                 a WIZARD genomic DNA purification kit (Promega,
   The aims of this study were firstly to analyze the          Milan, Italy), according to the manufacturer’s
effects of AD-expressing L. brevis-containing lozenges,        instructions.
both on the clinical signs of chronic periodontitis
patients and on the NOS activity levels, matrix metal-        Arginine deiminase activity
loproteinase (MMP) levels, eicosanoid generation, IgA         Arginine deiminase activity was determined in L. brevis
levels, IFN-c levels of the saliva. The mechanisms            extracts by measuring the conversion of [3H]-L-arginine to
underlying the anti-inflammatory effect of L. brevis            [3H]-L-citrulline. Samples were homogenized by sonica-
extract were investigated in vitro on rat peritoneal          tion in homogenization ice-cold buffer (25 mM Tris-HCl,
macrophages activated by lipopolysaccharide (LPS).            pH 7.4, 1 mM EDTA, 1 mM EGTA) containing protease
                                                              inhibitors (0.2 mM PMSF, 10 lg ml)1 aprotinin,
                                                              10 lg ml)1 pepstatin A and 10 l g ml)1 leupeptin). The
Materials and methods
                                                              homogenates were centrifuged at 4°C for 20 min at
                                                              11 000 g. The supernatants were passed through an
                                                              AG50WX-8 Dowex resin (Bio-Rad Laboratories, Mel-
Materials
                                                              ville, NY, USA) to remove endogenous arginine. The
Nitrate reductase, L-lactic dehydrogenase (LDH), pyru-        protein content was determined by the bicinchoninic acid
vic acid, b-nicotinamide adenine dinucleotide phosphate       procedure (BCA; Pierce, Rockford, IL, USA) using BSA
(NADPH), flavin adenine dinucleotide (FAD), flavin              as standard. Enzymatic reactions were conducted at 37°C
mononucleotide (FMN), (6R)-5,6,7,8-tetrahydrobiop-            for 30 min in 50 mM Tris-HCl, pH 7.4, containing 1 mM
terin (H4B), L-valine, phenylmethanesulfonyl fluoride          CaCl2, 1 mM MgCl2, 1 mM L-citrulline (to inhibit the
(PMSF), pepstatin A, leupeptin, aprotinin, ethylene           catabolism of [3H]-L-citrulline), 60 mM L-valine, 60 mM
glycol-bis      (2-aminoethlether)-N,N,N,‘N’-tetraacetic      L-ornithine, 60 mM L-lysine (to inhibit nonspecific argi-
acid (EGTA), ethylenediamine tetraacetic acid (EDTA),         nase activity) and 10 lCi ml)1 of [3H]-L-arginine (Amer-
4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid           sham, Bukinghamshire, UK). The reaction was stopped
(HEPES), Tris base, gelatin, Triton X-100, Coomassie          by the addition of 0.4 ml of stop buffer (50 mM HEPES,
brilliant blue and other chemicals were obtained from         pH 5.5, 5 mM EDTA). The samples were spotted onto
Sigma Aldrich srl (Milan, Italy). L-ornithine hydrochlo-      TLC plates and developed in chloroform/methanol/
ride and TPA were purchased from Alexis (San Diego,           ammonium hydroxide/water (1:4:2:1, by vol) as solvent
CA, USA). L-lisin monohydrochloride was obtained              system. After drying, the radiolabeled spots were visual-
from Merck (Merck Bioscience GmbH, Schwalback,                ized by autoradiography, after spraying EN3HANCER
Germany). EN3HANCE spray was obtained from                    (Perkin-Elmer Life and Analytical Sciences). [3H]-argin-
Perkin-Elmer (Perkin-Elmer Life and Analytical                ine and [3H]-citrulline, identified by co-chromatography
Sciences, Boston, MA, USA). Methanol, acetic acid,            with unlabeled standards which were revealed with
chloroform and ammonium hydroxide were purchased              ninhydrin spray, was scraped, and quantified by liquid
from J.T. Baker (Milan, Italy), Microconcentrators            scintillation. Where indicated, bacterial extracts were

                                                                                                                    Oral Diseases
Anti-inflammatory effects of L. brevis
                                                      DN Della Riccia et al

378
         preincubated for 60 min with 20 mM formamidine                           any patient, and antibiotics were not taken during the
         hydrochloride (Fluka Seelze, Germany), an inhibitor of                   previous 4 months. No patient was subjected to oral
         AD (Weikmann et al, 1978a,b).                                            hygienics. Before and after the treatment with lozenges,
                                                                                  the patients received a periodontal examination including
         Arginine deiminase gene PCR amplification                                 plaque index (Silness and Loe, 1964), gingival index,
                                                                                                                   ¨
         The oligonucleotides were designed on the bases of                       bleeding on probing, calculus and temperature sensitivity
         nucleotide sequences of AD genes conserved at EMBL                       scores. All periodontal disease measurements were per-
         and GeneBank databases (accession number AJ001330).                      formed in four quadrants at six sited per tooth for all
         For polymerase chain reaction (PCR) experiments the                      teeth, with the exception of plaque index for which four
         following primers were used: primer arcA1 frame                          sites were examined. The results were expressed as a mean
         5¢-ATTTGCACAAACATTACGAGAC and primer                                     value accompanied by standard error of the mean. The
         arcA2 reverse 5¢-GTGAAGACTGTATCTAAATG-                                   saliva samples, collected from controls and patients by
         CAT. Polymerase chain reaction (PCR) to amplify the                      spitting into an ice-cooled vessel before and after the
         AD-encoding gene, was performed in a 100 ll volume.                      treatment, were analyzed for MMP and NOS activity (the
         The amplification reaction mixture contained 2.5 U of                     latter determined as nitrite/nitrate levels in the fluid saliva
         AmpliTaq Gold DNA polymerase (Perkin-Elmer Life                          fraction and as citrulline levels in the cellular saliva
         and Analytical Sciences), the reaction buffer provided by                 fraction), and IgA, PGE2, IFN-c. Five patients, four men
         the Taq manufacturer (containing 1.5 mM MgCl2),                          and one women, 29–48 years old (mean age 40 ± 9.6)
         200 lM      each    deoxyribonucleotide     triphosphate                 manifesting periodontitis were also enrolled in the trial
         (dNTPs), 0.5 lM each primer, and 1 lg of genomic                         and treated for 4 days with conventional oral antibiotic
         DNA as template. Amplification reactions were carried                     therapy (spiromycin, 1 · 300 mg day)1) with the aim of
         out as follows: 12 min at 95° C for activation of                        comparing the effects of this conventional treatment with
         AmpliTaq Gold DNA polymerase; denaturation at 94°                        those exerted by the bacterial extracts of L. brevis. All
         C for 1 min, annealing at 55° C for 1 min, and extension                 participants were carefully informed of the aim of the
         at 72°C for 1 min, repeated for 30 cycles. A final DNA                    investigation and were free to withdraw from the study at
         extension step at 72°C for 7 min was allowed at the end                  any time. Written consent was obtained from all patients
         of the termal cycling. Direct sequencing of PCR ampl-                    prior to the collection of samples. The study was approved
         icons was performed on both strands by dideoxy-chain                     by the Institute of Odontoiatric Clinics of the La Sapienza
         termination method using a dRhodamina Terminator                         University, Rome, and was conducted in according with
         Cycle Sequencing Ready reaction Kit and the ABI                          the principles of the Declaration of Helsinki.
         PRISM 377 DNA Sequencer (Perkin-Elmer Life and
         Analytical Sciences). Sequencing was performed on three                  Animals
         PCR products derived from three independent reactions.                   Wistar rats (5–6 weeks old) were purchased from
                                                                                  Charles River Breeding Laboratories (Calco, Como,
         L. brevis-containing lozenges                                            Italy).
         Each lozenge (VSL Pharmaceuticals) was composed of
         the following: lyophilized bacteria (200 mg), fructose                   Rat peritoneal macrophages
         (400 mg), mannitole (1020 mg), aspartame (40 mg), talc                   Rat macrophages were obtained by peritoneal washes
         (60 mg), aerosil 200 (10 mg), Peg 6000 (50 mg), mag-                     with PBS, centrifuged and resuspended in Roswell Park
         nesium stearate (20 mg), tartaric acid (100 mg), and                     Memorial Institute (RPMI) 1640 medium containing
         orange flavor (100 mg).                                                   2 mM glutamine, 10% heat-inactivated fetal calf serum
                                                                                  (FCS) and 100 IU ml)1 penicillin and 100 lg ml)1
         Healthy volunteers, patients, treatment, and sample                      streptomycin. The cells were counted and their viability,
         collection                                                               as assessed by Trypan blue dye exclusion, was routinely
         The study was conducted as a double-blind paired-                        greater than 98%. Two milliliters of cell suspension
         comparison study, with treatment assignments random-                     (4 · 106cell ml)1) was then plated on a 12-well tissue
         ized and balanced to a group of eight healthy volunteers                 culture plate (Falcon; Becton Dickinson, Buccinasco,
         (people of our laboratories; male and female, age 24–                    Milan). The following day, cell cultures were washed
         47 years, mean age 33.6 ± 7.96), who were clinically free                thrice with medium without FCS and then cultured in
         of periodontal disease. Twenty-one patients with chronic                 the same medium for 18 h with or without LPS
         periodontitis, 16 men and five women, 30–51 years old                     (100 ng ml)1) in the presence or absence of bacterial
         (mean age 41.9 ± 7.23) were enrolled to analyze the effect                extracts (0.5 mg ml)1). At the end of the treatments, cell
         of L. brevis-containing lozenges (4 lozenges/day for                     pellets were used for NOS activity determination and
         4 days) on periodontitis-associated symptoms and signs,                  supernatants, concentrated 10-fold by Centricon C10
         from the clinical point of view. Patients in this study                  (Amicon, Millipore Co.), were used in zymogram
         displayed a range of periodontal disease from moderate to                experiments to detect metalloproteinase activity.
         severe periodontitis. Pocket depth, measured to the
         nearest millimeter marking, was >4 mm. Mean loss of                      Nitrite/nitrate levels
         attachment, evaluated by measuring the distance from the                 In aqueous solution, NO reacts rapidly with O2 and
         cemento-enamel junction to the bottom of the probing                     accumulates in the culture medium as nitrite and nitrate
         pocket, was 4.7 mm. No systemic disease was observed in                  ions. Twenty microliters of saliva samples or superna-

Oral Diseases
Anti-inflammatory effects of L. brevis
                                                            DN Della Riccia et al

                                                                                                                            379
tants from macrophage cultures was used for nitrite         activity was compared with that of partially purified
measurement by a colorimetric assay based on the Griess     gelatinases (MMP-2 and MMP-9) obtained from the
reaction. Briefly, 5 ll of HEPES (50 mM, pH 7.4), 5 ll       supernatants of HT1080 human fibrosarcoma cell line
of FAD (5 lM), 10 ll NADPH (0.1 mM), 58 ll of H2O           (ICLC HTL98016, Interlab Cell Line Collection, Genova,
and 2 ll of nitrate reductase (0.2 IU ml)1) were added to   Italy) stimulated with TPA (10)7M) for 48 h. All
20 ll of samples, which were then incubated for 30 min      experiments were conducted with or without EDTA,
at 37° C. At the end of the incubation time 10 ll of        serine or cystein proteinase inhibitors. Bands relative to
pyruvic acid (100 mM) and 1 ll of LDH (1500 IU ml)1)        enzyme activity were quantified by scanning densito-
were added to the samples. After 10 min of incubation at    metry using Molecular Analyst PCTM software for the
37° C, samples were mixed with an equal volume of           Bio-Rad model 670 scanning densitometer.
Griess reagent in a microtiter plate and incubated at
room temperature in the dark for 10 min. The OD was         Western blot
measured at 550 nm using a micro-enzyme-linked imu-         Saliva collected from healthy volunteers and patients
nosorbent assay (ELISA) reader (Easy Reader EAR 400;        were centrifuged at 600 g for 15 min and the superna-
Kontron Analytic, London, UK). KNO3 dissolved in            tants were assayed for protein using the BCA method
H2O was used as standard and H2O as blank.                  (Pierce). Twenty-eight microliters of each sample (40 lg
                                                            of protein) was mixed with 7 ll of nonreducing PAGE
Nitric oxide synthase activity                              buffer 5X [0.5 mol/l Tris-HCl (pH 6.8), 28% glycerol,
Nitric oxide synthase activity was determined in both       4.4% SDS, 0.55% bromophenol blue] and separated on
macrophage extracts and cell fraction of salivary sam-      an 8.5% polyacrylamide gel. After electrophoresis, SDS
ples by measuring the conversion of [3H]-L-arginine to      was removed by washing the gel in 50 mM Tris HCl pH
[3H]-L-citrulline as above described for AD assay. The      7.4, 2% Triton X-100 for 15 min at 37°C and then with
assay, performed with the addition to the reaction buffer    the same buffer lacking Triton X-100 for 15 min at 37°C.
of tetrahydrobiopterin (BH4), 2 lM FAD, 2 lM flavin          Afterwards, the gel was equilibrated in electrotransfer
adenine mononucleotide, CaCl2 (0.6 mM) and calmod-          buffer (25 mM Tris-HCl, 192 mM glycine, 10% meth-
ulin (CAM) (0.1 lM), measures both the calcium-             anol) for 20 min and transferred to polyvinyl difluoride
dependent (constitutive) and calcium-independent            (PVDF) membrane (Millipore) for 1 h at 4°C at 100V
(inducible) isoenzyme activities. Any activity inhibited    using a Mini Trans-Blot Cell apparatus (Bio-Rad
by AG or detected in the absence of Ca/CAM and in the       Laboratories, Hercules, CA, USA). Nonspecific binding
presence of the CAM antagonist W13 (100 lM) (to             sites were blocked with 10% nonfat dry milk in TBS-T
inhibit endogenous CAM), represented iNOS activity.         (TBS and 0.05% Tween 20) for 16 h at 4°C. The
Where indicated, 20 mM formamidine or 10 lM ami-            membrane was then incubated for 1 h at 25°C with a
noguanidine (AG) or 500 lM L-NMMA were added to             mouse monoclonal antihuman MMP-9 (Calbiochem-
the assay system to measure AD and/or NOS activity.         Novabiochem, Darmstadt, Germany) diluted 1:400 in
                                                            5% nonfat dry milk in TBS-T. After incubation the
Determination of saliva IFN-c, PGE2, and IgA levels         membrane was incubated for 1 h at 25°C with goat
The IFN-c (Endogen Inc., Woburn, MA, USA), PGE2             antimouse-horseradish peroxidase-conjugated IgG (San-
(Assay Designs) and IgA (IPR S.p.A., Catania, Italy)        ta Cruz Biotechnology, Santa Cruz, CA, USA) diluted
levels were determined in the fluid saliva fraction using    1:3000 in 2.5% non-fat dry milk in TBS-T. Immunore-
ELISA kits, according to the manufacturer’s instruc-        activity was assessed by chemiluminescence reaction
tions. Where indicated, PGE2 levels were also assessed      using ECL Western blotting detection system (Pierce).
in macrophage culture medium.
                                                            Statistical analysis
Substrate gel electrophoresis (zymogram)                    The differences in the analyzed parameters between the
SDS-PAGE zymograms containing 0.1% gelatin were             control and patient groups were tested by using the
performed as described previously (Thorgeirsson and         Student’s t-test. The statistical significance of the differ-
MacKay, 1992) using approximately 2 lg of sample            ences in clinical and laboratory parameters between T0
protein from saliva samples or cultured macrophage          and T1 was analyzed using the paired sample t-test.
supernatants to reveal the gelanolytic activity. Gelano-    The STATPAC program was used to perform statistical
lytic activity secreted by cultured macrophages in basal    analysis and statistical difference set at P < 0.05.
or stimulated conditions was analyzed using equal
10-fold concentrated sample volume (10–20 ll). Follow-
ing electrophoresis, gels were rinsed in 50 mM Tris-HCl
                                                            Results
(pH 7.4) containing 2% Triton X-100 followed by             Arginine deiminase activity in L. brevis extracts
50 mM Tris-HCl (pH 7.4) and incubated overnight for         Arginine deiminase activity was analyzed in bacterial
gelatinases, in a buffer containing 50 mM Tris-HCl (pH       extracts as described in the Materials and methods
7.4), 0.2 M NaCl, 5 mM CaCl2, and 1% Triton X-100 at        section. The enzymatic assay, based on the conversion
37°C. Enzyme activity was detected following staining       of L-arginine to L-citrulline in appropriate conditions
with 0.1% Coomassie brilliant blue in a mixture of          allowing to exclude NOS and arginase activity, showed
acetic acid:methanol:water (1:3:6), destained in the same   that AD activity was present at high levels in L. brevis
mixture without dye and dried. Sample collagenase           (Figure 1a). The generation of citrulline by L. brevis

                                                                                                                   Oral Diseases
Anti-inflammatory effects of L. brevis
                                                                                                      DN Della Riccia et al

380
         (a)
          Citrulline (pmol mg–1 prot min–1)                                                                   (b)
                                              45
                                              40
                                              35
                                              30
                                              25
                                              20
                                              15                                                                                  665 bp
                                              10
                                               5
                                               0
                                                              vis




                                                                         E


                                                                                     e
                                                             ne




                                                                                                                 Markers
                                                                       AM


                                                                                      n
                                                          bre




                                                                                   idi
                                                          idi


                                                                     -N


                                                                              uan
                                                        am
                                                   L.




                                                                    +L
                                                     orm




                                                                             nog
                                                   +F




                                                                           mi
                                                                         +A




                                                   (c)
                                                         5’                aaagaggttt ctagcgatgt           cttcgatggc      gtccgccgtc
                                                         gtccgaggga        aaccccaatt gctaagacgt           gtcggacaa       gacgagctcg
                                                         tcgccccctt        cgatgtggga ttcgtggttc           cggtcgcgcc      atacctcaac
                                                         ttgccccgca        aaccgtgggt ggtggttgat           gatgtattcc      gtgatcaggg                 Figure 1 Arginine deiminase expression in
                                                         attcacgttg        acgggccggg aaagtcatct           tgttaatgga      gatcccgtca                 Lactobacillus brevis extracts. (a) Arginine
                                                         ccaatggagg        cctgcggatc cgcgtgaag            taagcgtttg      gcattgggtc                 deiminase activity in bacterial extracts in the
                                                         cattaagaac        ggccagtccg tattttcgga           aacggattgc      agatccggtt                 presence or absence of formamidine, a specific
                                                         gggcgatgtc        aatgtcagtc ccccgcaccc           cttcgatgat      cttgtcaacc                 inhibitor of arginine deiminase, L-NMMA, a
                                                         atttcctgcg        gggtcatttg ggtagaggta           gtcatataag      gcgtcgtggg                 nitric oxide synthase (NOS) inhibitor, and
                                                         tggtacccgc        aacgtaacca gattcggcga           tcatccgg        3’                         aminoguanidine, a relatively specific inhibitor
                                                                                                                                                      of the inducible form of NOS. The results
                                                                                                                                                      represent the mean values of duplicate deter-
                                                   (d)         L. sakei        L DMVEKIMAGVRT NEIDIKSK
                                                                                                                                                      minations and are representative of one of
                                                               L. brevis       MET VDKI I EGVRGTDIDIAQP                                               three experiments. SD values were ever lower
                                                                                                                                                      than 10% of mean value. *P < 0.001 when
                                                               L. sakei        AL I DVSA - - - - - - - - - -- - - -                                   compared with L. brevis extracts alone. (b)
                                                               L. brevis       DLQSVSENTDWPFLMETDPME
                                                                                                                                                      Analysis of arginine deiminase gene, after
                                                               L. sakei        - - NLYFT RDPAASMGDGLTIN                                               PCR amplification performed on genomic
                                                               L. brevis       TPNAYFTRDPQAS I GDGI SIN                                               DNA, through 1.2% agarose gel electro-
                                                                                                                                                      phoresis. (c) Analysis of the direct sequencing
                                                               L. sakei        KM - -TFEARQRESMFMEVIMQ                                                of the PCR-obtained fragment amplimer
                                                               L. brevis       KMETTFPARQRESL I T EYI I N
                                                                                                                                                      (arcA1-2). (d) The sequence of a 124 amino
                                                               L. sakei        HHPRFANQGAQVWRDRDH IDR                                                 acid residue encoded by the PCR-obtained
                                                               L. brevis       HHPRFAGO– VEVWRDRNHESH                                                 fragment, corresponding to arginine deimi-
                                                                                                                                                      nase protein. The stringent homology (52%)
                                                               L. sakei        MEGGDEL ILSDKVLAIGIS
                                                               L. brevis       I EGGDELVLSDHVLAIGVS
                                                                                                                                                      with the arginine deiminase of L. sakei is
                                                                                                                                                      shown


         extract could be attributed to AD activity, as it was                                                                     124 amino acid residues which showed several conserved
         observed in the absence of NOS cofactors (NADPH,                                                                          structural elements typical of AD genes. Comparing
         FAD, FMN, and BH4) and it was not affected either by                                                                       amino acids residues of the AD of L. brevis and AD of
         L-valine, an arginase inhibitor, or by L-NMMA, a NOS                                                                      L. sakei (Figure 1d), a stringent homology (52%) was
         inhibitor, and aminoguanidine, a relatively specific                                                                       found. Although the AD gene is scarcely conserved,
         inhibitor of the inducible form of NOS. Moreover, the                                                                     including the internal regions, our results clearly
         abrogation of citrulline generation observed in the                                                                       demonstrated the presence of this gene in L. brevis.
         presence of formamidine, a specific inhibitor of AD,
         definitively established that the conversion of arginine to                                                                Clinical evaluation
         citrulline was due to the presence of high levels of this                                                                 The scores for gingival inflammation, plaque, tartar,
         enzyme in L. brevis extracts.                                                                                             temperature sensitivity, and bleeding on probing before
            The presence of AD in L. brevis was further con-                                                                       and after the treatment with L. brevis lozenges are
         firmed through the structural analysis of the gene                                                                         reported in Table 1. All clinical parameters that were
         encoding the enzyme. A couple of primers designed on                                                                      analyzed reached statistically significant differences
         the basis of consensus sequences known to be an                                                                           between patients before treatment (T0) and the same
         internal region of the AD encoding gene was used to                                                                       after treatment with L. brevis containing lozenges (T1).
         attempt PCR amplification. The PCR, performed on                                                                           On the mean, gingival inflammation was rated as
         genomic DNA of L. brevis, yielded an amplimer of                                                                          moderate/diffuse by 20 patients at enrollment, and mild
         665 bp (Figure 1b) which was subjected to direct                                                                          by one subject. After treatment, almost all patients
         sequencing. The sequencing of the PCR fragment,                                                                           showed no gingival inflammation; two individuals
         named arcA1-2, resulted in a completely identified                                                                         complained of a mild inflammation, while just one
         478 bp sequence (Figure 1c) encoding a polypeptide of                                                                     patient had a still moderate gingival inflammation. The

Oral Diseases
Anti-inflammatory effects of L. brevis
                                                                                  DN Della Riccia et al

                                                                                                                                                                   381
Table 1 Effect of the treatment with Lactobacillus brevis-containing




                                                                                                    HT1080
lozenges on gingival inflammation, plaque and calculus, temperature
sensitivity, and bleeding in periodontitis patients                                                                Healthy controls

                                  T0                 T1            P-value
                                                                                                                                                  250
Gingival inflammation       2.24   ±    0.12   0.14   ±    0.10     <0.0001                                                                        150
Plaque                     2.10   ±    0.14   1.10   ±    0.12     <0.0001                92                                                      100
Calculus                   1.62   ±    0.21   1.29   ±    0.16     <0.0001
                                                                                                                                                  75
Temperature sensitivity    2.29   ±    0.14   0.43   ±    0.11     <0.0001                72
Bleeding                   1.38   ±    0.19   0.05   ±    0.05     <0.0001                                                                        50
                                                                                                                                                  37
tolerability was considered as very good by all patients.
Overall, the clinical evaluation of both the dentist and
the patient overlapped, and the results confirmed
recovery in 18 patients and improvement in three
individuals. The antibiotic treatment for 4 days did                                                                                              250
                                                                                                                                                  150
not significantly modify signs and symptoms (data not                                      92                                                      100
shown), as expected.                                                                                                                              75
                                                                                          72
Effects of L. brevis-containing lozenges on saliva sample                                                                                          50
NOS activity, PGE2, IFN-c, and IgA levels                                                                                                         37
The levels of nitrites and nitrates and those of PGE2,
IFN-c, and IgA, determined in the fluid saliva fraction
of healthy controls and periodontitis patients, as
described in Materials and methods in an unblinded

                                                                                                        HT1080
fashion, are reported in Table 2. Periodontitis patients’
saliva had a significantly higher level of nitrites/nitrates                                                               Patients
when compared with normal subjects (P < 0.01). In the
same Table are also reported the results obtained when                            Figure 2 Salivary matrix metalloproteinase (MMP) activity in healthy
periodontitis patients’ saliva was analyzed for nitrite/                          subjects and periodontitis patients. Gelatinase activity in the soluble
nitrate levels before (T0) and after (T1) treatment with                          salivary fractions of representative healthy subjects and periodontitis
L. brevis-containing lozenges. In all patients, the treat-                        patients is shown. The electrophoretic mobility of MMP-9 and MMP-
                                                                                  2, obtained from supernatants of HT1080 cell, is indicated on the left-
ment was associated with a significant reduction in                                hand side. Molecular weights of the standard are indicated on the right
nitrite and nitrate levels. Similar results were obtained
when the conversion of radiolabeled arginine to citrul-
line was analyzed in the cell saliva fraction (data not
shown). In addition the PGE2 and IFN-c levels were                                amounts of MMPs than the control samples, thus
significantly higher in patients with periodontitis than in                        confirming previous reports. Figure 2 shows gelatinase
controls (P < 0.01). Interestingly, treatment with                                activity present in five different control salivary samples
L. brevis-containing lozenges was associated with a                               (panel a) as well as in five different patients’ salivary
strong decrease in the levels of these inflammation-                               samples (panel b), representative of all examined cases.
associated molecules (P < 0.01). In contrast, IgA levels,                         Enzymatic activity was compared with that of gelatin-
which were significantly reduced in patients compared                              ases obtained from the supernatants of the HT1080 cell
with controls (P < 0.05), were not significantly mod-                              line stimulated with tissue plasminogen activator (TPA)
ified by the treatment.                                                            (10)7 M) for 48 h (the 72 kDa type IV collagenase,
                                                                                  gelatinase A, MMP-2, and the 92 kDa type IV collag-
Effects of L. brevis-containing lozenges on saliva sample                          enase, gelatinase B, MMP-9). The zymogram of healthy
MMP activity and levels                                                           control salivas (Figure 2a) shows bands with relative
The measurements of MMP activity in the soluble                                   molecular weights of 92 kDa, of about 120 kDa and
fraction of saliva samples disclosed that the salivary                            higher than 200 kDa. Aside from a band of about
samples of periodontitis patients contained higher                                37 kDa, little or no enzymatic activity was visible at


Table 2 Effect of the treatment with Lactobacillus brevis-containing lozenges on laboratory parameters in periodontitis patients

Samples               Nitrite/nitrate (lM)                       PGE2 (ng ml)1)                  IFN-c (pg ml)1)                          IgA (lg ml)1)

HC                  4.33 ± 1.31 P < 0.0001                       0.32 ± 0.08                    10.06 ± 0.84                         885.62 ± 118.28
T0                 38.86 ± 6.07* P < 0.0001                      1.64 ± 0.1*                    28.23 ± 2.11*                        309.76 ± 143.06*P < 0.05
T1                  9.39 ± 1.47**                                0.46 ± 0.07**                   8.82 ± 4.74**1.04                   466.51 ± 237.1

HC, healthy controls; T0, before treatment; T1, after treatment. *P ¼ T0 vs HC; **P ¼ T1 vs T0.


                                                                                                                                                          Oral Diseases
Anti-inflammatory effects of L. brevis
                                                               DN Della Riccia et al

382
         molecular weights lower than 92 kDa. The profile of
         multiple forms of gelatinases found in patients’ saliva is
         shown in Figure 2b. In addition to the same bands of                                      250
         controls, a strong gelatinolytic activity at molecular                                    150
         weights lower than 92 kDa could be seen in all patients’
         salivas. In some cases (i.e., lanes 2 and 3) the high                                     100
         molecular weight activities of gelatinase were almost                                      75
         absent, being prevailing below 92 kDa. These latter
         species mainly migrated with a connecting smear, being
         evident as separate bands only at the 37–50 kDa region.                                    50
         The gelatinolytic activity detected by zimogram
         appeared to be due to the presence of MMPs, as
         protease activity was completely abrogated by the                                                      C    T0        T1   T0       T1   T0 T1
         addition of EDTA, but not by the addition of serine                                          Patient n.           4             5          6
         and cysteine proteinase inhibitors to the incubation
         buffer (data not shown). The treatment with lozenges led                           Figure 4 Effects of Lactobacillus brevis-containing lozenges on saliva
                                                                                           sample matrix metalloproteinase levels. Western blot analysis of
         to the near disappearance of these MMP bands in all                               gelatinase expression in one representative healthy control and three
         patients’ samples. Figure 3 shows the gelatinolytic activ-                        periodontitis patients’ saliva samples before and after treatment with
         ity of five representative periodontitis patients before                           lozenges containing L. brevis. C, healthy control; T0, before treatment;
         (T0) and after (T1) the treatment with experimental                               T1, after treatment. Molecular mass markers are indicated on the left-
                                                                                           hand side
         lozenges. The profile of multiple forms of gelatinases
         was similar in all patients. The treatment led to the near
         disappearance of the low molecular weight bands and                               92 kDa were detected. Western blotting with specific
         restored the control profile of gelatinolytic activity.                            antibodies against human MMP-2, MMP-3, MMP-1,
            Western blot experiments demonstrated that the bands                           and MMP-8 showed no immunoreactivity, suggesting
         revealed by zymograms were due mainly to the enzymatic                            that these MMPs were not detectable in the saliva of either
         activity of MMP-9. Figure 4 shows a Western blot of one                           controls or patients (data not shown).
         representative control and three representative patients
         before and after treatment with experimental lozenges. In                         Effect of L. brevis extracts on macrophage NOS activity
         the saliva of patients antibody against MMP-9 revealed                            Rat peritoneal macrophages incubated in vitro in the
         some high molecular weight forms (>200 kDa) together                              presence of LPS for 18 h were induced to express iNOS
         with bands at the 180 kDa region and at 120 kDa. Other                            activity (Figure 5a). NOS activity was inhibited by the
         molecular weights ranging from 92 to 64 kDa and                                   NOS inhibitors AG and L-NMMA. In the presence of
         approximately at 54 and 44 kDa were seen in the saliva                            bacterial extracts, NOS activity disappeared and argin-
         of patients with chronic periodontitis. After treatment the                       ine was converted in citrulline through bacterial AD,
         enzymatic pattern resembled that of healthy controls.                             as demonstrated either by the unsensitivity of this
         Indeed, a relevant reduction in high molecular weight                             conversion to NOS inhibitor treatment (Figure 5a) or
         bands was observed and little or no MMP-9 species below                           by the disappearance of enzymatic activity in the
                                                                                           presence of the AD inhibitor, formamidine (data not
                                                                                           shown). Similar results were obtained with L. fermentum
                                                                                  250      extracts, but not with Streptococcus thermophilus, a
                                                                                  150      LAB in which the AD activity was not detectable (not
                                                                                  100      shown).
         92
                                                                                  75         These results suggest that bacterial AD was able to
         72                                                                       50       totally utilize the arginine present in the medium thus
                                                                                  37       preventing its uptake by macrophages and consequently
                                                                                           NOS activity.

                                                                                           Effect of L. brevis extracts on macrophage PGE2 release
                                                                                           When rat peritoneal macrophages were cultured for up
                  HT1080




                           T0 T1 T0 T1      T0 T1 T0 T1 T0 T1
                                                                                           to 18 h with LPS, a gradual accumulation of PGE2 in
                                                                                           the supernatants occurred (fivefold increase over that in
                            4       5         7           3           6                    control cells) (Figure 5b). This effect was almost totally
                                          Patient n.                                       abrogated in the presence of L. brevis extracts as
         Figure 3 Effects of Lactobacillus brevis-containing lozenges on saliva            occurred when the cells were previously treated with
         sample matrix metalloproteinase (MMP) activity. Zymography com-                   L-NMMA or aminoguanidine.
         paring gelatinolitic activities in saliva of five periodontitis patients
         before treatment (T0) with gelatinolitic activities in saliva of the same         Effect of L. brevis extracts on MMP production by
         patients after treatment with L. brevis-containing lozenges (T1). The
         electrophoretic mobility of MMP-9 and MMP-2, obtained from                        macrophages in the presence of LPS
         supernatants of HT1080 cell line, is indicated on the left-hand side.             To investigate the L. brevis effect on MMP production,
         Molecular weights of the standard are indicated on the right-hand side            activated rat peritoneal macrophages were treated with

Oral Diseases
Anti-inflammatory effects of L. brevis
                                                                                             DN Della Riccia et al

                                                                                                                                                                                                              383
                                                (a)                                  3                                                                          Control
                                                                                                                                                                L. brevis




                                                Citrulline (pmol mg–1 prot min–1)
                                                                                    2.5                                                                         LPS
                                                                                                                                                                LPS + L. brevis
                                                                                     2

                                                                                    1.5

                                                                                     1

                                                                                    0.5

                                                                                     0
                                                                                          None                L-NAME                 Aminoguanidine             Formamidine




                                                                                                                                                                                LPS + L. brevis
                                                (b) 60                                               Control                            (c)
                                                                                                     L. brevis
                                                                                                     LPS
                                                    PGE2 (ng/106 cells)
                                                                                    50




                                                                                                                                                      HT 1080
                                                                                                     LPS+ L.brevis




                                                                                                                                                                                                  L. brevis
                                                                                                                                                                Control
Figure 5 Effect of Lactobacillus brevis                                                              LPS+ L-NMMA
                                                                                                     LPS+ AG




                                                                                                                                                                          LPS
extracts on LPS-activated macrophages.                                              40
Effect of L. brevis extracts on iNOS activity
(a), PGE2 levels (b) and MMP activity (c) in                                        30
rat peritoneal macrophages incubated in vitro                                                                                           MMP9
in the presence or absence of LPS for 18 h.                                         20
Where indicated, the effect of L-NMMA,
                                                                                    10                                                  MMP2
aminoguanidine (AG), and formamidine is
shown                                                                                0



bacterial extracts in the presence or absence of LPS and                                     enzymatic activity (Di Marzio et al, 2001), we checked
cell culture supernatants were analyzed by zymography                                        the presence of the AD gene. The analysis of a fragment
for MMP-9 and MMP-2 levels. Compared with macr-                                              obtained by PCR unambiguously revealed the presence
ophages in culture medium alone, LPS increased MMP-                                          of this gene, thus confirming our previous findings.
9 activity, whereas MMP-2 was not detectable. The                                               Nitric oxide is known to be an important inflamma-
presence of L. brevis extract in the culture medium led to                                   tory mediator, and is involved in the pathophysiology of
a relevant decrease in MMP-9 activity, either when                                           several inflammatory disorders. An increase in NO
added alone or in the presence of stimuli. Similarly, a                                      production has been also demonstrated in periodontitis
total inhibition of MMP activity was observed in the                                         as its role in the inflammatory response of periodontal
presence of iNOS inhibitors. A representative zymogra-                                       tissues has been suggested (Matejka et al, 1998, 1999;
phy is illustrated in Figure 5c. Enzymatic activity was                                      Lappin et al, 2000; Hirose et al, 2001; Kendall et al,
compared with that of partially purified gelatinases                                          2001; Lohinai et al, 2001; Daghigh et al, 2002). These
(MMP-2 and MMP-9) obtained from the supernatants                                             findings are consistent with the hypothesis suggesting
of HT1080 cell line stimulated with TPA (10)7M) for                                          that treatment with agents able to block the production
48 h. The bands revealed by zymograms could be                                               of NO or its effects might be therapeutically valuable for
attributed to MMPs as they disappear with EDTA but                                           periapical lesions (Lohinai et al, 1998; Paquette and
not by the addition of other proteinase inhibitors to the                                    Williams, 2000; Daghigh et al, 2002). Considering the
incubation buffer (data not shown).                                                           role of NO in inflammatory events in general and in
                                                                                             periodontitis in particular, we analyzed the potential
                                                                                             beneficial effects of L. brevis-based treatment in patients
Discussion                                                                                   with periodontal disease. Of note, the proposed experi-
Periodontitis is characterized by extensive destruction of                                   mental treatment led to the total disappearance or
the gingival tissues and associated supporting structures                                    amelioration of all analyzed clinical parameters (gingi-
of the teeth. In the present work, we first analyzed the                                      val inflammation, plaque, calculus, temperature sensi-
potential anti-inflammatory action in vivo of L. brevis-                                      tivity, and bleeding on probing) in almost all 21 patients
containing lozenges in 21 adult patients with periodontal                                    (recovery in 18 patients and improvement in three
disease. Previously, our group reported the presence of                                      individuals). The beneficial effects of the treatment on
arginine-deiminase in L. brevis, a strain belonging to                                       clinical signs and symptoms were paralleled by a strong
LAB (Di Marzio et al, 2001). The presence of high levels                                     and statistically significant decrease in oral NOS activ-
of this enzyme, which metabolize arginine to citrulline                                      ity. Besides its direct role as an inflammatory modulator,
and ammonia, aids L. brevis extracts to inhibit NO                                           NO represents a multifunctional messenger molecule
generation, by competing with NOS for the same                                               able to modulate the production of inflammatory
substrate, arginine. To confirm the presence of AD in                                         cytokines (Cifone et al, 1999), PGE2 (Goodwin et al,
L. brevis, previously shown through the assay of                                             1999), and MMPs (Maeda et al, 1998; Tronc et al, 2000;

                                                                                                                                                                                                     Oral Diseases
Anti-inflammatory effects of L. brevis
                                                        DN Della Riccia et al

384
         Hirai et al, 2001). On the other hand, inflammatory                         exclude the possibility that L. brevis extract-based
         cytokines such as IFN-c, tumor necrosis factor-a and                       treatment, besides the anti-inflammatory effects repor-
         interleukin-1-a have been shown to be significantly                         ted here, is also able to antagonize the growth of specific
         higher in periodontitis patients than in healthy controls                  periodontopathic pathogens.
         (Takeichi et al, 2000; Hirose et al, 2001; Tervahartiala                      Taken together, our findings give further insights into
         et al, 2001; Ukai et al, 2001). Moreover, the generation                   the knowledge of the molecular basis of periodontitis
         of PGE2, a potent eicosanoid lipid mediator derived                        and have a potential clinical significance, representing
         from phospholipase-released arachidonic acid that is                       the experimental ground for a new innovative, simple
         involved in numerous homeostatic biologic functions                        and efficacious therapeutical approach of periodontal
         and inflammation, has been shown to be strongly                             disease.
         incremented in periodontal lesions (Cavanaugh et al,
         1998; Leibur et al, 1999; Paquette and Williams, 2000;
                                                                                    Acknowledgements
         Tsilingaridis et al, 2003). Furthermore, MMP levels
         have been previously shown to play a critical role in the                  The authors thank Gasperina De Nuntiis (Department of
         inflammatory process leading to alveolar bone and                           Experimental Medicine, University of L’Aquila, L’Aquila,
         connective tissue loss in periodontal disease (Makela                      Italy) for technical assistance and Miss Florence Pryen for
         et al, 1994; Ding et al, 1995; Ejeil et al, 2003; Sorsa et al,             careful language revision of the manuscript. This work was
         2004). Indeed, one of the most salient features of                         financially supported by grant ÔPROGETTO DI INTERESSE
                                                                                    GENERALE DI ATENEO’ from the University of L’Aquila.
         periodontitis and gingivitis is the increase in the levels of
         bacterial and host-derived proteolytic enzymes in oral
         inflammatory exudates. Bacterial pathogens involved in                      References
         periodontal diseases partly trigger and induce host cells                  Baron AC, Gansky SA, Ryder MI et al (1999). Cysteine
         to elevate their secretion of MMP. Proteolytic enzymes                        protease inhibitory activity and levels of salivary cystatins in
         released by the host cells and/or by pathogen bacteria                        whole saliva of periodontally diseased patients. J Periodon-
         are associated with tissue destruction and MMP have                           tal Res 34: 437–444.
         the primary role in this process as they can degrade most                  Bodana AR, Rao DR (1990). Antimutagenic activity of milk
         of the extracellular matrix components (Ding et al,                           fermented by Streptococcus thermophilus and Lactobacillus
         1995).                                                                        bulgaricus. J Dairy Sci 73: 3379–3384.
            Altogether, these observations prompted us to ana-                      Caglar E, Kargul B, Tanboga I (2005). Bacteriotherapy and
                                                                                     ¸
         lyze the potential effects of L. brevis extracts containing                    probiotics’ role on oral health. Oral Dis 11: 131–137.
         lozenges on IFN-c, PGE2, and MMP salivary levels in                        Cavanaugh PFJR, Meredith MP, Buchanan W et al (1998).
                                                                                       Coordinate production of PGE2 and IL-1 beta in the
         periodontitis patients. Our findings clearly showed that                       gingival crevicular fluid of adults with periodontitis: its
         all these inflammatory-associated factors were drastic-                        relationship to alveolar bone loss and disruption by twice
         ally reduced in periodontal disease patients after the                        daily treatment with ketorolac tromethamine oral rinse.
         L. brevis-based treatment. However, no significant                             J Periodontal Res 33: 75–82.
         effects were observed on salivary IgA levels after the                                          `
                                                                                    Cifone MG, D’alo S, Parroni R et al (1999). Interleukin-2-
         proposed treatment.                                                           activated rat natural killer cells express inducible nitric oxide
            In the attempt to define the mechanisms underlying                          synthase that contributes to cytotoxic function and inter-
         the anti-inflammatory action of L-brevis-based treat-                          feron-gamma production. Blood 93: 3876–3884.
         ment, a set of experiments were performed by using rat                     Daghigh F, Borghaei RC, Thornton RD et al (2002). Human
         peritoneal macrophages activated in vitro with LPS in                         gingival fibroblasts produce nitric oxide in response to
                                                                                       proinflammatory cytokines. J Periodontol 73: 392–400.
         the presence or absence of bacterial extracts. The results                 Di Marzio L, Russo PF, Biordi L et al (2001). Apoptotic
         indicated that the LPS-induced iNOS activity, PGE2                            effects of selected strains of lactic acid bacteria on a human
         generation, and MMP activation were almost totally                            T leukaemia cell line are associated with bacterial arginine
         abrogated when macrophages were cultured in the                               deiminase and/or sphingomyelinase activities. Nutr Cancer
         presence of bacterial extracts, thus strongly supporting                      40: 185–196.
         the in vivo observations. The finding that iNOS inhib-                      Ding Y, Uitto VJ, Firth J et al (1995). Modulation of host
         itors were able to inhibit either PGE2 release or MMP                         matrix metalloproteinases by bacterial virulence factors
         activity in LPS-activated macrophages, prompted us to                         relevant in human periodontal diseases. Oral Dis 1: 279–286.
         hypothesize that NO could be responsible for the latter                    Dugas B, Mercenier A, Lenoir-Wijnkoop I et al (1999).
         events, as previously reported in several systems (Maeda                      Immunity and probiotics. Immunol Today 20: 387–390.
                                                                                    Ejeil AL, Igondjo-Tchen S, Ghomrasseni S et al (2003).
         et al, 1998; Goodwin et al, 1999; Tronc et al, 2000;                          Expression of matrix metalloproteinases (MMPs) and tissue
         Hirai et al, 2001). The anti-inflammatory effects of                            inhibitors of metalloproteinases (TIMPs) in healthy and
         L. brevis extracts could thus be attributed to their                          diseased human gingiva. J Periodontol 2: 188–195.
         ability to prevent iNOS activity and, consequently                         Golub LM, Ryan ME, Williams RC (1998). Modulation of the
         NO-dependent PGE2 release and MMP activation.                                 host response in the treatment of periodontitis. Dent Today
            Considering recent reports showing that Lactobacillus                      17: 102–106.
         and Bifidobacterium spp. or their components protected                      Goodwin DC, Landino LM, Marnett LJ (1999). Effects of
         the host against certain oral diseases by inhibiting the                      nitric oxide and nitric oxide-derived species on prostaglan-
         growth of potential pathogens (Smith et al, 2001;                             din endoperoxide synthase and prostaglandin biosynthesis.
         Grudianov et al, 2002; Volozhin et al, 2004), we cannot                       FASEB J 13: 1121–1136.


Oral Diseases
Anti-inflammatory effects of L. brevis
                                                                    DN Della Riccia et al

                                                                                                                                         385
Gorbach SL (2000). Probiotics and gastrointestinal health. Am       McGee JM, Tucci MA, Edmundson TP et al (1998). The
  J Gastroenterol 95 (Suppl. 1): S2–S4.                                relationship between concentrations of proinflammatory
Graves DT (1999). The potential role of chemokines and                 cytokines within gingival and the adjacent sulcural depth.
  inflammatory cytokines in periodontal disease progression.            J Periodontol 69: 865–871.
  Clin Infect Dis 28: 482–490.                                      Offenbacher S (1996). Periodontal diseases: pathogenesis. Ann
Grudianov AI, Dmitrieva NA, Fomenko EV (2002). Use of                  Periodontol 1: 821–878.
  probiotics Bifidumbacterin and Acilact in tablets in therapy       Paquette DW, Williams RC (2000). Modulation of host
  of periodontal inflammation. Stomatologiia Mosk 81: 39–43.            inflammatory mediators as a treatment strategy for perio-
Henskens YM, Van Den Keijbus PA, Veeman EC et al (1996).               dontal diseases. Periodontol 2000 24: 239–252.
  Protein composition of whole and parotid saliva in healthy        Roberfroid MB (1998). Prebiotics and synbiotics: concepts and
  and periodontitis subjects. Determination of cystatins,              nutritional properties. Br J Nutr 80: S197–S220.
  albumin, amylase and IgA. J Periodontol Res 31: 57–65.            Schenk K, Poppelsdorf D, Denis C et al (1993). Levels of
Hirai Y, Migita K, Honda S et al (2001). Effects of nitric oxide        salivary IgA antibodies reactive with bacteria from dental
  on matrix metalloproteinase-2 production by rheumatoid               plaque are associated with susceptibility to experimental
  synovial cells. Life Sci 68: 913–920.                                gingivitis. J Clin Periodontol 20: 411–417.
Hirose M, Ishihara K, Saito A et al (2001). Expression of           Silness J, Loe H (1964). Periodontal disease in pregnancy. II.
                                                                                  ¨
  cytokines and inducible nitric oxide synthase inflamed                Correlation between oral hygiene and periodontal condi-
  gingival tissue. J Periodontol 72: 590–597.                          tion. Acta Odontol Scand 22: 121–135.
Ishii Y, Ogura T, Tatemichi M et al (2003). Induction of            Smith SI, Aweh AJ, Coker AO et al (2001). Lactobacilli in
  matrix metalloproteinase gene transcription by nitric oxide          human dental caries and saliva. Microbios 105: 77–85.
  and mechanisms of MMP-1 gene induction in human                   Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloprotein-
  melanoma cell lines. Int J Cancer 103: 161–168.                      ases (MMPs) in oral diseases. Oral Dis 6: 311–318 (Review).
Kendall HK, Marshall RI, Bartold PM (2001). Nitric oxide            Takeichi O, Haber J, Kawai T et al (2000). Cytokine profiles
  and tissue destruction. Oral Dis 7: 2–10.                            of T-lymphocytes from gingival tissues with pathological
Konings WN, Kok J, Kuipers OP et al (2000). Lactic acid                pocketing. J Dent Res 79: 1548–1555.
  bacteria: the bugs of the new millennium. Curr Opin               Tervahartiala T, Koski H, Xu JW et al (2001). Tumor necrosis
  Microbiol 3: 276–282.                                                factor-alpha and its receptors, p55 and p75, in gingiva of
Kornman KS (1999). Host modulation as a therapeutic                    adult periodontitis. J Dent Res 80: 1684–1687.
  strategy in the treatment of periodontal disease. Clin Infect     Thorgeirsson UP, MacKay AR (1992). Characterization of
  Dis 28: 520–526.                                                     metastatic tumor cell. In: Gallegner CT, Rees RC, Reynolds
Korostoff JM, Wang JF, Sarment DP et al (2000). Analysis of             CW, eds. Tumor immunology: a practical approach. Univer-
  in situ protease activity in chronic adult periodontitis             sity Press: Oxford, pp. 82–90.
  patients: expression of activated MMP-2 and a 40 kDa              Travis J, Potemba J (2000). Bacterial proteinases as targets for
  serine protease. J Periodontol 71: 353–360                           the development of second-generation antibiotics. Biochim
Lappin DF, Kjeldsen M, Sander L et al (2000). Inducible nitric         Biophys Acta 1477: 35–50.
  oxide synthase expression in periodontitis. J Periodontal Res     Tronc F, Mallat Z, Lehoux S et al (2000). Role of matrix
  35: 369–373.                                                         metalloproteinases in blood flow-induced arterial enlarge-
Leibur E, Tuhkanen A, Pintson U et al (1999). Prostaglandin            ment: interaction with NO. Arterioscler Thromb Vasc Biol
  E2 levels in blood plasma and in crevicular fluid of advanced         20: E120–E126.
  periodontitis patients before and after surgical therapy. Oral    Tsai CC, Hong CC, Chen CC et al (1998). Measurement of
  Dis 5: 223–228.                                                      prostaglandin E2 and leukotriene B4 in the gingival crevic-
Lohinai Z, Benedek P, Feher E et al (1998). Protective effects          ular fluid. J Dent 26: 97–103.
  of mercaptoethylguanidine, a selective inhibitor of inducible     Tsilingaridis G, Yucel-Lindberg T, Modeer T (2003). Enhanced
  nitric oxide synthase, in ligature-induced periodontitis in the      levels of prostaglandin E2, leukotriene B4, and matrix
  rat. Br J Pharmacol 123: 353–357.                                    metalloproteinase-9 in gingival crevicular fluid from patients
Lohinai Z, Stachlewitz R, Virag L et al (2001). Evidence for           with Down syndrome. Acta Odontol Scand 3: 154–158.
  reactive nitrogen species formation in the gingivomucosal         Ukai T, Mori Y, Onoyama M et al (2001). Immunohistolog-
  tissue. J Dental Res 80: 470–475.                                    ical study of interferon-gamma- and interleukin-4-bearing
Maeda H, Okamoto T, Akaike T (1998). Human matrix                      cells in human periodontitis gingival. Arch Oral Biol 46:
  metalloproteinase activation by insults of bacterial infection       901–908.
  involving proteases and free radicals. Biol Chem 379:             Volozhin AI, Il’in VK, Maksimovskii IuM et al (2004).
  193–200.                                                             Development and use of periodontal dressing of collagen
Makela M, Salo T, Uitto VJ et al (1994). Matrix metallopro-            and Lactobacillus casei 37 cell suspension in combined
  teinases (MMP-2 and MMP-9) of the oral cavity: cellular              treatment of periodontal disease of inflammatory origin (a
  origin and relationship to periodontal status. J Dental Res          microbiological study). Stomatologiia (Mosk) 83: 6–8
  73: 1397–1406.                                                    Weikmann JL, Himmel ME, Smith DW et al (1978a). Argin-
Matejka M, Partyka L, Ulm C et al (1998). Nitric oxide                 ine deiminase: demonstration of two active sites and possible
  synthesis is increased in periodontal disease. J Periodontal         half-of-the-sites reactivity. Biochem Biophys Res Commun
  Res 33: 517–518.                                                     83: 107–113.
Matejka M, Ulm C, Partyka L et al (1999). Nitric oxide              Weikmann L, Himmel ME, Squire PG et al (1978b). Arginine
  synthesis is increased in periodontitis. Adv Exp Med Biol            deiminase from Mycoplasma arthritidis. Properties of the
  469: 419–424.                                                        enzyme from log phase cultures. J Biol Chem 253: 6010–6015.




                                                                                                                                Oral Diseases

Weitere ähnliche Inhalte

Was ist angesagt?

Article1381823084 mahfouz and al shammrani
Article1381823084 mahfouz and al shammraniArticle1381823084 mahfouz and al shammrani
Article1381823084 mahfouz and al shammraniTaqprimer institute
 
Effects of the association between a calcium hydroxide
Effects of the association between a calcium hydroxideEffects of the association between a calcium hydroxide
Effects of the association between a calcium hydroxideCharles Pereira
 
Christian Mueller ABIO 399 paper 12 16 15
Christian Mueller ABIO 399 paper 12 16 15Christian Mueller ABIO 399 paper 12 16 15
Christian Mueller ABIO 399 paper 12 16 15Christian Mueller
 
Sortase A Inhibition By Ugi Products
Sortase A Inhibition By Ugi ProductsSortase A Inhibition By Ugi Products
Sortase A Inhibition By Ugi Productsdavidabulger
 
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...pryloock
 
Impact of heavy metals pollution on molecular genetics of some medicinal plants
Impact of heavy metals pollution on molecular genetics of some medicinal plantsImpact of heavy metals pollution on molecular genetics of some medicinal plants
Impact of heavy metals pollution on molecular genetics of some medicinal plantsIOSRJAVS
 
nii korley kortei (microbiology)
nii korley kortei (microbiology)nii korley kortei (microbiology)
nii korley kortei (microbiology)Nii Korley Kortei
 
simona cavalu_alumina zirconia ceramic implant
simona cavalu_alumina zirconia ceramic implantsimona cavalu_alumina zirconia ceramic implant
simona cavalu_alumina zirconia ceramic implantSimona Cavalu
 
Incidence of lipolytic mycoflora in domestic wastewater
Incidence of lipolytic mycoflora in domestic wastewaterIncidence of lipolytic mycoflora in domestic wastewater
Incidence of lipolytic mycoflora in domestic wastewaterAlexander Decker
 
Biosensors and Bioelectr
Biosensors and Bioelectr Biosensors and Bioelectr
Biosensors and Bioelectr Charles Zhang
 
Article1380717788 cao et al
Article1380717788 cao et alArticle1380717788 cao et al
Article1380717788 cao et alDon Rahul
 
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...Premier Publishers
 
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...IOSR Journals
 
Gonadal histo morphology and antifertility effects of bonny light crude oil i...
Gonadal histo morphology and antifertility effects of bonny light crude oil i...Gonadal histo morphology and antifertility effects of bonny light crude oil i...
Gonadal histo morphology and antifertility effects of bonny light crude oil i...Alexander Decker
 
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...lukeman Joseph Ade shittu
 

Was ist angesagt? (19)

Article1381823084 mahfouz and al shammrani
Article1381823084 mahfouz and al shammraniArticle1381823084 mahfouz and al shammrani
Article1381823084 mahfouz and al shammrani
 
Williams-etal_2011_ES&T_Antibacterial-clays_es1040688
Williams-etal_2011_ES&T_Antibacterial-clays_es1040688Williams-etal_2011_ES&T_Antibacterial-clays_es1040688
Williams-etal_2011_ES&T_Antibacterial-clays_es1040688
 
Effects of the association between a calcium hydroxide
Effects of the association between a calcium hydroxideEffects of the association between a calcium hydroxide
Effects of the association between a calcium hydroxide
 
Christian Mueller ABIO 399 paper 12 16 15
Christian Mueller ABIO 399 paper 12 16 15Christian Mueller ABIO 399 paper 12 16 15
Christian Mueller ABIO 399 paper 12 16 15
 
Sortase A Inhibition By Ugi Products
Sortase A Inhibition By Ugi ProductsSortase A Inhibition By Ugi Products
Sortase A Inhibition By Ugi Products
 
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...
Conceição et al, 2012. potamotrygon cf. henlei stingray mucus biochemical fea...
 
Impact of heavy metals pollution on molecular genetics of some medicinal plants
Impact of heavy metals pollution on molecular genetics of some medicinal plantsImpact of heavy metals pollution on molecular genetics of some medicinal plants
Impact of heavy metals pollution on molecular genetics of some medicinal plants
 
Varney_2015
Varney_2015Varney_2015
Varney_2015
 
nii korley kortei (microbiology)
nii korley kortei (microbiology)nii korley kortei (microbiology)
nii korley kortei (microbiology)
 
simona cavalu_alumina zirconia ceramic implant
simona cavalu_alumina zirconia ceramic implantsimona cavalu_alumina zirconia ceramic implant
simona cavalu_alumina zirconia ceramic implant
 
Incidence of lipolytic mycoflora in domestic wastewater
Incidence of lipolytic mycoflora in domestic wastewaterIncidence of lipolytic mycoflora in domestic wastewater
Incidence of lipolytic mycoflora in domestic wastewater
 
Proposal seminar
Proposal seminarProposal seminar
Proposal seminar
 
Biosensors and Bioelectr
Biosensors and Bioelectr Biosensors and Bioelectr
Biosensors and Bioelectr
 
Article1380717788 cao et al
Article1380717788 cao et alArticle1380717788 cao et al
Article1380717788 cao et al
 
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Re...
 
Probiotics and adhesion paper
Probiotics and adhesion paperProbiotics and adhesion paper
Probiotics and adhesion paper
 
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...
Characterization of Arsenic contaminated Rice (Oryza Sativa L.) through RAPD ...
 
Gonadal histo morphology and antifertility effects of bonny light crude oil i...
Gonadal histo morphology and antifertility effects of bonny light crude oil i...Gonadal histo morphology and antifertility effects of bonny light crude oil i...
Gonadal histo morphology and antifertility effects of bonny light crude oil i...
 
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...
Spermatotoxic impact of bonny light crude oil (BLCO) ingestion on adult male ...
 

Ähnlich wie Anti-inflammatory doc effects of Lactobacillus brevis CD2 on periodontal disease

The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...
The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...
The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...MerqurioEditore_redazione
 
Aggressive-Periodontitis-1-202110221533460.pptx
Aggressive-Periodontitis-1-202110221533460.pptxAggressive-Periodontitis-1-202110221533460.pptx
Aggressive-Periodontitis-1-202110221533460.pptxPRAGYARATHORE24
 
Aggressive periodontitis
Aggressive periodontitisAggressive periodontitis
Aggressive periodontitisShalini Dubey
 
Journal club microbial shift in periodontics
Journal club microbial shift in periodonticsJournal club microbial shift in periodontics
Journal club microbial shift in periodonticsDr. Virshali Gupta
 
The role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progressionThe role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progressionHope Inegbenosun
 
s13568-014-0042-y
s13568-014-0042-ys13568-014-0042-y
s13568-014-0042-yIan Durie
 
Grant Proposal (S00127084)
Grant Proposal (S00127084)Grant Proposal (S00127084)
Grant Proposal (S00127084)Mohammed Kazzeh
 
gastroprotective role of nitric oxide
gastroprotective role of nitric oxide gastroprotective role of nitric oxide
gastroprotective role of nitric oxide Owonikoko Mathew
 
HOST MODULATION THERAPY- Part 1.pptx
HOST MODULATION THERAPY- Part 1.pptxHOST MODULATION THERAPY- Part 1.pptx
HOST MODULATION THERAPY- Part 1.pptxDr K. Abhilasha
 
ISOLATION AND IDENTIFICATION OF LACTIC ACID BACTERIA FROM PLANTS AND OTHER ...
ISOLATION AND IDENTIFICATION OF LACTIC  ACID BACTERIA FROM PLANTS AND OTHER  ...ISOLATION AND IDENTIFICATION OF LACTIC  ACID BACTERIA FROM PLANTS AND OTHER  ...
ISOLATION AND IDENTIFICATION OF LACTIC ACID BACTERIA FROM PLANTS AND OTHER ...American Research Thoughts
 
Aggressive periodontitis ul
Aggressive periodontitis ulAggressive periodontitis ul
Aggressive periodontitis ulLeena Parmar
 
Royal jelly accelerates recovery from oral mucositis
Royal jelly accelerates recovery from oral mucositisRoyal jelly accelerates recovery from oral mucositis
Royal jelly accelerates recovery from oral mucositisBee Healthy Farms
 
Host Modulation..pptx
Host Modulation..pptxHost Modulation..pptx
Host Modulation..pptxMumtaz Ali
 
Advances in Nanomaterial with Antimicrobial Activity
Advances in Nanomaterial with Antimicrobial ActivityAdvances in Nanomaterial with Antimicrobial Activity
Advances in Nanomaterial with Antimicrobial Activityendale Kebede
 
P gingivalis
P gingivalis P gingivalis
P gingivalis mikitha p
 
Omics related approaches for higher productivity and improved quality.pptx
Omics related approaches for higher productivity and improved quality.pptxOmics related approaches for higher productivity and improved quality.pptx
Omics related approaches for higher productivity and improved quality.pptxAnirudhTV
 

Ähnlich wie Anti-inflammatory doc effects of Lactobacillus brevis CD2 on periodontal disease (20)

The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...
The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...
The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric ...
 
Aggressive-Periodontitis-1-202110221533460.pptx
Aggressive-Periodontitis-1-202110221533460.pptxAggressive-Periodontitis-1-202110221533460.pptx
Aggressive-Periodontitis-1-202110221533460.pptx
 
Gingival Crevicular Fluid
Gingival Crevicular FluidGingival Crevicular Fluid
Gingival Crevicular Fluid
 
Aggressive periodontitis
Aggressive periodontitisAggressive periodontitis
Aggressive periodontitis
 
Journal club microbial shift in periodontics
Journal club microbial shift in periodonticsJournal club microbial shift in periodontics
Journal club microbial shift in periodontics
 
The role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progressionThe role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progression
 
s13568-014-0042-y
s13568-014-0042-ys13568-014-0042-y
s13568-014-0042-y
 
Grant Proposal (S00127084)
Grant Proposal (S00127084)Grant Proposal (S00127084)
Grant Proposal (S00127084)
 
gastroprotective role of nitric oxide
gastroprotective role of nitric oxide gastroprotective role of nitric oxide
gastroprotective role of nitric oxide
 
Impact of Metal Oxide Nanoparticles on Beneficial Soil Microorganisms and the...
Impact of Metal Oxide Nanoparticles on Beneficial Soil Microorganisms and the...Impact of Metal Oxide Nanoparticles on Beneficial Soil Microorganisms and the...
Impact of Metal Oxide Nanoparticles on Beneficial Soil Microorganisms and the...
 
HOST MODULATION THERAPY- Part 1.pptx
HOST MODULATION THERAPY- Part 1.pptxHOST MODULATION THERAPY- Part 1.pptx
HOST MODULATION THERAPY- Part 1.pptx
 
periodontitis and rheumatoid arthritis.pptx
periodontitis and rheumatoid arthritis.pptxperiodontitis and rheumatoid arthritis.pptx
periodontitis and rheumatoid arthritis.pptx
 
ISOLATION AND IDENTIFICATION OF LACTIC ACID BACTERIA FROM PLANTS AND OTHER ...
ISOLATION AND IDENTIFICATION OF LACTIC  ACID BACTERIA FROM PLANTS AND OTHER  ...ISOLATION AND IDENTIFICATION OF LACTIC  ACID BACTERIA FROM PLANTS AND OTHER  ...
ISOLATION AND IDENTIFICATION OF LACTIC ACID BACTERIA FROM PLANTS AND OTHER ...
 
Aggressive periodontitis ul
Aggressive periodontitis ulAggressive periodontitis ul
Aggressive periodontitis ul
 
Vaccines R&D 08-11 final2.pdf
Vaccines R&D 08-11 final2.pdfVaccines R&D 08-11 final2.pdf
Vaccines R&D 08-11 final2.pdf
 
Royal jelly accelerates recovery from oral mucositis
Royal jelly accelerates recovery from oral mucositisRoyal jelly accelerates recovery from oral mucositis
Royal jelly accelerates recovery from oral mucositis
 
Host Modulation..pptx
Host Modulation..pptxHost Modulation..pptx
Host Modulation..pptx
 
Advances in Nanomaterial with Antimicrobial Activity
Advances in Nanomaterial with Antimicrobial ActivityAdvances in Nanomaterial with Antimicrobial Activity
Advances in Nanomaterial with Antimicrobial Activity
 
P gingivalis
P gingivalis P gingivalis
P gingivalis
 
Omics related approaches for higher productivity and improved quality.pptx
Omics related approaches for higher productivity and improved quality.pptxOmics related approaches for higher productivity and improved quality.pptx
Omics related approaches for higher productivity and improved quality.pptx
 

Mehr von MerqurioEditore_redazione

Stomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiStomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiMerqurioEditore_redazione
 
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoLe onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoMerqurioEditore_redazione
 
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità MerqurioEditore_redazione
 
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...MerqurioEditore_redazione
 
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreGruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreMerqurioEditore_redazione
 
Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...MerqurioEditore_redazione
 
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...MerqurioEditore_redazione
 
Canali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webCanali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webMerqurioEditore_redazione
 
e-Detailing: la comunicazione medico scientifica con efficacia promozional
e-Detailing: la comunicazione medico scientifica  con efficacia promozionale-Detailing: la comunicazione medico scientifica  con efficacia promozional
e-Detailing: la comunicazione medico scientifica con efficacia promozionalMerqurioEditore_redazione
 
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
Supplemento di ferro e vitamnine  in donne anemiche in gravidanzaSupplemento di ferro e vitamnine  in donne anemiche in gravidanza
Supplemento di ferro e vitamnine in donne anemiche in gravidanzaMerqurioEditore_redazione
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaMerqurioEditore_redazione
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaMerqurioEditore_redazione
 
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaApprocci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaMerqurioEditore_redazione
 
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...MerqurioEditore_redazione
 

Mehr von MerqurioEditore_redazione (20)

Stomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamentiStomatite aftosa ricorrente classificazione e trattamenti
Stomatite aftosa ricorrente classificazione e trattamenti
 
Micosi e amorolfina
Micosi e amorolfinaMicosi e amorolfina
Micosi e amorolfina
 
Antimicotici
AntimicoticiAntimicotici
Antimicotici
 
Il controllo delle micosi gli antifungini
Il controllo delle micosi  gli antifunginiIl controllo delle micosi  gli antifungini
Il controllo delle micosi gli antifungini
 
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamentoLe onicopatie. prevenzione, diagnosi differenziale e trattamento
Le onicopatie. prevenzione, diagnosi differenziale e trattamento
 
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
Sondaggi e analisi di mercato online e telefonici: efficienza e rapidità
 
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
Phone-detailing: efficienza nell’informazione scientifica ed efficacia nella ...
 
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio EditoreGruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
Gruppo Merqurio: Merqurio Pharma – Merqurio Servizi – Merqurio Editore
 
Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...Medical Information Service: servizio di consulenza scientifica in ricerche B...
Medical Information Service: servizio di consulenza scientifica in ricerche B...
 
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
CSO Merqurio: la rete di informazione scientifica conto terzi oggi è dotata d...
 
Canali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul webCanali online: la comunicazione scientifica professionale sul web
Canali online: la comunicazione scientifica professionale sul web
 
e-Detailing: la comunicazione medico scientifica con efficacia promozional
e-Detailing: la comunicazione medico scientifica  con efficacia promozionale-Detailing: la comunicazione medico scientifica  con efficacia promozional
e-Detailing: la comunicazione medico scientifica con efficacia promozional
 
Emostasi
EmostasiEmostasi
Emostasi
 
Emostasi
EmostasiEmostasi
Emostasi
 
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
Supplemento di ferro e vitamnine  in donne anemiche in gravidanzaSupplemento di ferro e vitamnine  in donne anemiche in gravidanza
Supplemento di ferro e vitamnine in donne anemiche in gravidanza
 
Linee guida per la fibrillazione atriale
Linee guida per la fibrillazione atrialeLinee guida per la fibrillazione atriale
Linee guida per la fibrillazione atriale
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
 
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenzaUlipristal acetato, nuovo farmaco per la contraccezione d'emergenza
Ulipristal acetato, nuovo farmaco per la contraccezione d'emergenza
 
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsonianaApprocci bioenergetici per la neuroprotezione nella malattia parkinsoniana
Approcci bioenergetici per la neuroprotezione nella malattia parkinsoniana
 
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
La conduzione del nervo surale dorsale in pazienti con carenza di vitamina B1...
 

Kürzlich hochgeladen

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 

Kürzlich hochgeladen (20)

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 

Anti-inflammatory doc effects of Lactobacillus brevis CD2 on periodontal disease

  • 1. Oral Diseases (2007) 13, 376–385. doi:10.1111/j.1601-0825.2006.01291.x Ó 2007 The Authors. Journal compilation Ó 2007 Blackwell Munksgaard All rights reserved http://www.blackwellmunksgaard.com ORIGINAL ARTICLE Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease DN Della Riccia1, F Bizzini1, MG Perilli2, A Polimeni3, V Trinchieri4, G Amicosante2 and MG Cifone1 1 Department of Experimental Medicine, University of L’Aquila, L’Aquila, Italy; 2Department of Biomedical Sciences and Technologies, University of L’Aquila, L’Aquila, Italy; 3Department of Odontostomatologic Sciences, University ÔLa Sapienza’, Rome, Italy; 4Department of Infectious and Tropical Diseases, University ÔLa Sapienza’, Rome, Italy OBJECTIVES: To analyze the anti-inflammatory effects Introduction of Lactobacillus brevis extracts on periodontitis patients and to investigate the involved mechanisms in vitro on Lactic acid bacteria (LAB) belong to a variety of genera activated macrophages. used for milk fermentation. The primary metabolic end METHODS: Eight healthy subjects and 21 patients with product from carbohydrate metabolism is lactic acid, chronic periodontitis were enrolled to analyze the effect which in turn preserves milk by providing the acidity of L. brevis-containing lozenges on periodontitis-associ- necessary for a tart flavor and for changes in the ated symptoms and signs. Before and after the treat- structure of casein to achieve syneresis and desired ment, the patients received a complete periodontal functional characteristics. The extensive knowledge on examination. Saliva samples, collected before and after LAB has opened new possibilities for their application treatment, were analyzed for metalloproteinase and ni- (for reviews see Konings et al, 2000; Caglar et al, 2005). ¸ tric oxide synthase (NOS) activity, immunoglobulin-A Reports of many investigators have confirmed that LAB (IgA), prostaglandin E2 (PGE2) and c-interferon (IFN-c) and their products have beneficial effects on the health levels. Arginine deiminase (AD) and NOS activities were of animals and humans, i.e., protection against enteric determined through a radiometric assay. Metallopro- infections, use as an oral adjuvant, immunopotentiation teinases were assayed by zymogram and Western blot- in malnutrition, and prevention of chemically induced ting, whereas IgA, PGE2 and IFN-c were assayed by tumors (Bodana and Rao, 1990; Roberfroid, 1998; enzyme-linked imunosorbent assay tests. Dugas et al, 1999; Gorbach, 2000). Almost all genera of RESULTS: The treatment led to the total disappearance LAB are able to produce bacteriocins that are primarily or amelioration of all analyzed clinical parameters in all lethal to other strains and species of bacteria form short- patients. This was paralleled to a significant decrease of lived pores in biologic membranes by interactions with nitrite/nitrate, PGE2, matrix metalloproteinase, and IFN- different compounds including nisin, lipid II and c levels in saliva samples. phospholipids, thereby killing the target bacteria (Kon- CONCLUSION: Our results suggest that the anti- ings et al, 2000). In the attempt to better characterize the inflammatory effects of L. brevis could be attributed to metabolic features of some LAB strains, our group has the presence of AD which prevented nitric oxide gen- recently shown the presence of high levels of arginine eration. Our findings give further insights into the deiminase (AD) in Lactobacillus brevis (Di Marzio et al, knowledge of the molecular basis of periodontitis and 2001). As bacterial AD may compete with nitric oxide have a potential clinical significance, giving the experi- synthase (NOS) by using the same substrate, arginine, mental ground for a new innovative, simple and effica- we decided to investigate the ability of L. brevis extracts cious therapeutical approach of periodontal disease. to inhibit NOS activity as well other inflammatory Oral Diseases (2007) 13, 376–385 parameters [c-interferon (IFN-c), prostaglandin E2 (PGE2) and metalloproteinases], known to be associated Keywords: L. brevis; nitric oxide; metalloproteinases; prostaglan- with NOS induction (Cifone et al, 1999; Goodwin et al, din E2; c-interferon 1999; Di Marzio et al, 2001; Ishii et al, 2003). In particular, the chronic periodontal disease was chosen as the known inflammatory model to test the potential Corresponding Author: Dr MG Cifone, Department of Experimental in vivo anti-inflammatory effects of L. brevis. Medicine, University of L’Aquila, Via Vetoio, 10, Coppito 2, 67100 Periodontal disease is a major cause of tooth loss in L’Aquila, Italy. Tel: 0862 433503, Fax: 0862 433523, E-mail: pres- humans and is one of the most prevalent diseases med@cc.univaq.it associated with bone loss. Following bacterial coloniza- Received 19 November 2006; revised 9 January 2006; accepted 30 January 2006 tion, the gingiva becomes inflamed leading, in some cases,
  • 2. Anti-inflammatory effects of L. brevis DN Della Riccia et al 377 to the destruction of the alveolar bone. Periodontitis has (Centricon 10) from Amicon (Amicon, Millipore Co., two distinct but interconnected etiologic components: Bedford, MA, USA). IFN-c (Endogen, Inc., Walburn, periodontopathic bacteria adjacent to the periodontal MA, USA) and PGE2 Elisa kits (Assay Designs Inc., tissues, and host-mediated connective tissue-destructive Ann Arbor, MI, USA) were purchased from TEMA responses to the causative bacteria and their metabolic ricerca srl (Bologna, Italy). IgAs Elisa kits were products (Golub et al, 1998). Treatment strategies obtained from IPR (Catania, Italy). against periodontal diseases have evolved with the aim of eliminating specific pathogens or suppressing destruc- Preparation of bacterial extracts tive host response. Although the pathogenesis of the Lactobacillus brevis, obtained from VSL Pharmaceuti- various forms of this disease is not completely under- cals (Gaithersburg, MD, USA) in a pure lyophilized stood, several factors are believed to play an important form (108 colony-forming units per gram), was routinely role, including inflammatory cytokines (McGee et al, grown in MRS broth medium under aerobic conditions. 1998; Graves, 1999), PGE2 (Offenbacher, 1996; Tsai et al, For the determination of AD activity and for in vitro 1998; Kornman, 1999), nitric oxide (Matejka et al, 1999; experiments on macrophages, L. brevis cultures were Takeichi et al, 2000) and salivary immunoglobulin-A washed and resuspended in 10 ml phosphate-buffered (IgA) antibodies (Schenk et al, 1993). Moreover, many of solution (PBS), sonicated (30 min, alternating 10 s the characteristics of periodontal diseases such as inflam- sonication and 10 s pause) with a Vibracell sonicator mation and attachment loss are associated with proteo- (Sonic and Materials Inc., Danbury, CT, USA), centri- lytic events. Indeed, oral damage can result from the fuged at 7500 g for 20 min at 4°C and the supernatants release of an array of proteolytic enzymes by colonizing stored at )20°C until used (bacterial extract). For bacteria as well as host-derived proteases (Henskens et al, the in vitro experiments, the bacterial extract was 1996; Baron et al, 1999; Korostoff et al, 2000; Travis and added to cell cultures at 0.5 mg/105cells/1 ml)1 (final Potemba, 2000). Selection of an appropriate delivery concentration). system is an important factor and, periodontitis being a For gene expression studies, genomic DNA was Ôlocalized’ disease condition, local drug treatment should isolated from an overnight culture of L. brevis using be preferred. a WIZARD genomic DNA purification kit (Promega, The aims of this study were firstly to analyze the Milan, Italy), according to the manufacturer’s effects of AD-expressing L. brevis-containing lozenges, instructions. both on the clinical signs of chronic periodontitis patients and on the NOS activity levels, matrix metal- Arginine deiminase activity loproteinase (MMP) levels, eicosanoid generation, IgA Arginine deiminase activity was determined in L. brevis levels, IFN-c levels of the saliva. The mechanisms extracts by measuring the conversion of [3H]-L-arginine to underlying the anti-inflammatory effect of L. brevis [3H]-L-citrulline. Samples were homogenized by sonica- extract were investigated in vitro on rat peritoneal tion in homogenization ice-cold buffer (25 mM Tris-HCl, macrophages activated by lipopolysaccharide (LPS). pH 7.4, 1 mM EDTA, 1 mM EGTA) containing protease inhibitors (0.2 mM PMSF, 10 lg ml)1 aprotinin, 10 lg ml)1 pepstatin A and 10 l g ml)1 leupeptin). The Materials and methods homogenates were centrifuged at 4°C for 20 min at 11 000 g. The supernatants were passed through an AG50WX-8 Dowex resin (Bio-Rad Laboratories, Mel- Materials ville, NY, USA) to remove endogenous arginine. The Nitrate reductase, L-lactic dehydrogenase (LDH), pyru- protein content was determined by the bicinchoninic acid vic acid, b-nicotinamide adenine dinucleotide phosphate procedure (BCA; Pierce, Rockford, IL, USA) using BSA (NADPH), flavin adenine dinucleotide (FAD), flavin as standard. Enzymatic reactions were conducted at 37°C mononucleotide (FMN), (6R)-5,6,7,8-tetrahydrobiop- for 30 min in 50 mM Tris-HCl, pH 7.4, containing 1 mM terin (H4B), L-valine, phenylmethanesulfonyl fluoride CaCl2, 1 mM MgCl2, 1 mM L-citrulline (to inhibit the (PMSF), pepstatin A, leupeptin, aprotinin, ethylene catabolism of [3H]-L-citrulline), 60 mM L-valine, 60 mM glycol-bis (2-aminoethlether)-N,N,N,‘N’-tetraacetic L-ornithine, 60 mM L-lysine (to inhibit nonspecific argi- acid (EGTA), ethylenediamine tetraacetic acid (EDTA), nase activity) and 10 lCi ml)1 of [3H]-L-arginine (Amer- 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid sham, Bukinghamshire, UK). The reaction was stopped (HEPES), Tris base, gelatin, Triton X-100, Coomassie by the addition of 0.4 ml of stop buffer (50 mM HEPES, brilliant blue and other chemicals were obtained from pH 5.5, 5 mM EDTA). The samples were spotted onto Sigma Aldrich srl (Milan, Italy). L-ornithine hydrochlo- TLC plates and developed in chloroform/methanol/ ride and TPA were purchased from Alexis (San Diego, ammonium hydroxide/water (1:4:2:1, by vol) as solvent CA, USA). L-lisin monohydrochloride was obtained system. After drying, the radiolabeled spots were visual- from Merck (Merck Bioscience GmbH, Schwalback, ized by autoradiography, after spraying EN3HANCER Germany). EN3HANCE spray was obtained from (Perkin-Elmer Life and Analytical Sciences). [3H]-argin- Perkin-Elmer (Perkin-Elmer Life and Analytical ine and [3H]-citrulline, identified by co-chromatography Sciences, Boston, MA, USA). Methanol, acetic acid, with unlabeled standards which were revealed with chloroform and ammonium hydroxide were purchased ninhydrin spray, was scraped, and quantified by liquid from J.T. Baker (Milan, Italy), Microconcentrators scintillation. Where indicated, bacterial extracts were Oral Diseases
  • 3. Anti-inflammatory effects of L. brevis DN Della Riccia et al 378 preincubated for 60 min with 20 mM formamidine any patient, and antibiotics were not taken during the hydrochloride (Fluka Seelze, Germany), an inhibitor of previous 4 months. No patient was subjected to oral AD (Weikmann et al, 1978a,b). hygienics. Before and after the treatment with lozenges, the patients received a periodontal examination including Arginine deiminase gene PCR amplification plaque index (Silness and Loe, 1964), gingival index, ¨ The oligonucleotides were designed on the bases of bleeding on probing, calculus and temperature sensitivity nucleotide sequences of AD genes conserved at EMBL scores. All periodontal disease measurements were per- and GeneBank databases (accession number AJ001330). formed in four quadrants at six sited per tooth for all For polymerase chain reaction (PCR) experiments the teeth, with the exception of plaque index for which four following primers were used: primer arcA1 frame sites were examined. The results were expressed as a mean 5¢-ATTTGCACAAACATTACGAGAC and primer value accompanied by standard error of the mean. The arcA2 reverse 5¢-GTGAAGACTGTATCTAAATG- saliva samples, collected from controls and patients by CAT. Polymerase chain reaction (PCR) to amplify the spitting into an ice-cooled vessel before and after the AD-encoding gene, was performed in a 100 ll volume. treatment, were analyzed for MMP and NOS activity (the The amplification reaction mixture contained 2.5 U of latter determined as nitrite/nitrate levels in the fluid saliva AmpliTaq Gold DNA polymerase (Perkin-Elmer Life fraction and as citrulline levels in the cellular saliva and Analytical Sciences), the reaction buffer provided by fraction), and IgA, PGE2, IFN-c. Five patients, four men the Taq manufacturer (containing 1.5 mM MgCl2), and one women, 29–48 years old (mean age 40 ± 9.6) 200 lM each deoxyribonucleotide triphosphate manifesting periodontitis were also enrolled in the trial (dNTPs), 0.5 lM each primer, and 1 lg of genomic and treated for 4 days with conventional oral antibiotic DNA as template. Amplification reactions were carried therapy (spiromycin, 1 · 300 mg day)1) with the aim of out as follows: 12 min at 95° C for activation of comparing the effects of this conventional treatment with AmpliTaq Gold DNA polymerase; denaturation at 94° those exerted by the bacterial extracts of L. brevis. All C for 1 min, annealing at 55° C for 1 min, and extension participants were carefully informed of the aim of the at 72°C for 1 min, repeated for 30 cycles. A final DNA investigation and were free to withdraw from the study at extension step at 72°C for 7 min was allowed at the end any time. Written consent was obtained from all patients of the termal cycling. Direct sequencing of PCR ampl- prior to the collection of samples. The study was approved icons was performed on both strands by dideoxy-chain by the Institute of Odontoiatric Clinics of the La Sapienza termination method using a dRhodamina Terminator University, Rome, and was conducted in according with Cycle Sequencing Ready reaction Kit and the ABI the principles of the Declaration of Helsinki. PRISM 377 DNA Sequencer (Perkin-Elmer Life and Analytical Sciences). Sequencing was performed on three Animals PCR products derived from three independent reactions. Wistar rats (5–6 weeks old) were purchased from Charles River Breeding Laboratories (Calco, Como, L. brevis-containing lozenges Italy). Each lozenge (VSL Pharmaceuticals) was composed of the following: lyophilized bacteria (200 mg), fructose Rat peritoneal macrophages (400 mg), mannitole (1020 mg), aspartame (40 mg), talc Rat macrophages were obtained by peritoneal washes (60 mg), aerosil 200 (10 mg), Peg 6000 (50 mg), mag- with PBS, centrifuged and resuspended in Roswell Park nesium stearate (20 mg), tartaric acid (100 mg), and Memorial Institute (RPMI) 1640 medium containing orange flavor (100 mg). 2 mM glutamine, 10% heat-inactivated fetal calf serum (FCS) and 100 IU ml)1 penicillin and 100 lg ml)1 Healthy volunteers, patients, treatment, and sample streptomycin. The cells were counted and their viability, collection as assessed by Trypan blue dye exclusion, was routinely The study was conducted as a double-blind paired- greater than 98%. Two milliliters of cell suspension comparison study, with treatment assignments random- (4 · 106cell ml)1) was then plated on a 12-well tissue ized and balanced to a group of eight healthy volunteers culture plate (Falcon; Becton Dickinson, Buccinasco, (people of our laboratories; male and female, age 24– Milan). The following day, cell cultures were washed 47 years, mean age 33.6 ± 7.96), who were clinically free thrice with medium without FCS and then cultured in of periodontal disease. Twenty-one patients with chronic the same medium for 18 h with or without LPS periodontitis, 16 men and five women, 30–51 years old (100 ng ml)1) in the presence or absence of bacterial (mean age 41.9 ± 7.23) were enrolled to analyze the effect extracts (0.5 mg ml)1). At the end of the treatments, cell of L. brevis-containing lozenges (4 lozenges/day for pellets were used for NOS activity determination and 4 days) on periodontitis-associated symptoms and signs, supernatants, concentrated 10-fold by Centricon C10 from the clinical point of view. Patients in this study (Amicon, Millipore Co.), were used in zymogram displayed a range of periodontal disease from moderate to experiments to detect metalloproteinase activity. severe periodontitis. Pocket depth, measured to the nearest millimeter marking, was >4 mm. Mean loss of Nitrite/nitrate levels attachment, evaluated by measuring the distance from the In aqueous solution, NO reacts rapidly with O2 and cemento-enamel junction to the bottom of the probing accumulates in the culture medium as nitrite and nitrate pocket, was 4.7 mm. No systemic disease was observed in ions. Twenty microliters of saliva samples or superna- Oral Diseases
  • 4. Anti-inflammatory effects of L. brevis DN Della Riccia et al 379 tants from macrophage cultures was used for nitrite activity was compared with that of partially purified measurement by a colorimetric assay based on the Griess gelatinases (MMP-2 and MMP-9) obtained from the reaction. Briefly, 5 ll of HEPES (50 mM, pH 7.4), 5 ll supernatants of HT1080 human fibrosarcoma cell line of FAD (5 lM), 10 ll NADPH (0.1 mM), 58 ll of H2O (ICLC HTL98016, Interlab Cell Line Collection, Genova, and 2 ll of nitrate reductase (0.2 IU ml)1) were added to Italy) stimulated with TPA (10)7M) for 48 h. All 20 ll of samples, which were then incubated for 30 min experiments were conducted with or without EDTA, at 37° C. At the end of the incubation time 10 ll of serine or cystein proteinase inhibitors. Bands relative to pyruvic acid (100 mM) and 1 ll of LDH (1500 IU ml)1) enzyme activity were quantified by scanning densito- were added to the samples. After 10 min of incubation at metry using Molecular Analyst PCTM software for the 37° C, samples were mixed with an equal volume of Bio-Rad model 670 scanning densitometer. Griess reagent in a microtiter plate and incubated at room temperature in the dark for 10 min. The OD was Western blot measured at 550 nm using a micro-enzyme-linked imu- Saliva collected from healthy volunteers and patients nosorbent assay (ELISA) reader (Easy Reader EAR 400; were centrifuged at 600 g for 15 min and the superna- Kontron Analytic, London, UK). KNO3 dissolved in tants were assayed for protein using the BCA method H2O was used as standard and H2O as blank. (Pierce). Twenty-eight microliters of each sample (40 lg of protein) was mixed with 7 ll of nonreducing PAGE Nitric oxide synthase activity buffer 5X [0.5 mol/l Tris-HCl (pH 6.8), 28% glycerol, Nitric oxide synthase activity was determined in both 4.4% SDS, 0.55% bromophenol blue] and separated on macrophage extracts and cell fraction of salivary sam- an 8.5% polyacrylamide gel. After electrophoresis, SDS ples by measuring the conversion of [3H]-L-arginine to was removed by washing the gel in 50 mM Tris HCl pH [3H]-L-citrulline as above described for AD assay. The 7.4, 2% Triton X-100 for 15 min at 37°C and then with assay, performed with the addition to the reaction buffer the same buffer lacking Triton X-100 for 15 min at 37°C. of tetrahydrobiopterin (BH4), 2 lM FAD, 2 lM flavin Afterwards, the gel was equilibrated in electrotransfer adenine mononucleotide, CaCl2 (0.6 mM) and calmod- buffer (25 mM Tris-HCl, 192 mM glycine, 10% meth- ulin (CAM) (0.1 lM), measures both the calcium- anol) for 20 min and transferred to polyvinyl difluoride dependent (constitutive) and calcium-independent (PVDF) membrane (Millipore) for 1 h at 4°C at 100V (inducible) isoenzyme activities. Any activity inhibited using a Mini Trans-Blot Cell apparatus (Bio-Rad by AG or detected in the absence of Ca/CAM and in the Laboratories, Hercules, CA, USA). Nonspecific binding presence of the CAM antagonist W13 (100 lM) (to sites were blocked with 10% nonfat dry milk in TBS-T inhibit endogenous CAM), represented iNOS activity. (TBS and 0.05% Tween 20) for 16 h at 4°C. The Where indicated, 20 mM formamidine or 10 lM ami- membrane was then incubated for 1 h at 25°C with a noguanidine (AG) or 500 lM L-NMMA were added to mouse monoclonal antihuman MMP-9 (Calbiochem- the assay system to measure AD and/or NOS activity. Novabiochem, Darmstadt, Germany) diluted 1:400 in 5% nonfat dry milk in TBS-T. After incubation the Determination of saliva IFN-c, PGE2, and IgA levels membrane was incubated for 1 h at 25°C with goat The IFN-c (Endogen Inc., Woburn, MA, USA), PGE2 antimouse-horseradish peroxidase-conjugated IgG (San- (Assay Designs) and IgA (IPR S.p.A., Catania, Italy) ta Cruz Biotechnology, Santa Cruz, CA, USA) diluted levels were determined in the fluid saliva fraction using 1:3000 in 2.5% non-fat dry milk in TBS-T. Immunore- ELISA kits, according to the manufacturer’s instruc- activity was assessed by chemiluminescence reaction tions. Where indicated, PGE2 levels were also assessed using ECL Western blotting detection system (Pierce). in macrophage culture medium. Statistical analysis Substrate gel electrophoresis (zymogram) The differences in the analyzed parameters between the SDS-PAGE zymograms containing 0.1% gelatin were control and patient groups were tested by using the performed as described previously (Thorgeirsson and Student’s t-test. The statistical significance of the differ- MacKay, 1992) using approximately 2 lg of sample ences in clinical and laboratory parameters between T0 protein from saliva samples or cultured macrophage and T1 was analyzed using the paired sample t-test. supernatants to reveal the gelanolytic activity. Gelano- The STATPAC program was used to perform statistical lytic activity secreted by cultured macrophages in basal analysis and statistical difference set at P < 0.05. or stimulated conditions was analyzed using equal 10-fold concentrated sample volume (10–20 ll). Follow- ing electrophoresis, gels were rinsed in 50 mM Tris-HCl Results (pH 7.4) containing 2% Triton X-100 followed by Arginine deiminase activity in L. brevis extracts 50 mM Tris-HCl (pH 7.4) and incubated overnight for Arginine deiminase activity was analyzed in bacterial gelatinases, in a buffer containing 50 mM Tris-HCl (pH extracts as described in the Materials and methods 7.4), 0.2 M NaCl, 5 mM CaCl2, and 1% Triton X-100 at section. The enzymatic assay, based on the conversion 37°C. Enzyme activity was detected following staining of L-arginine to L-citrulline in appropriate conditions with 0.1% Coomassie brilliant blue in a mixture of allowing to exclude NOS and arginase activity, showed acetic acid:methanol:water (1:3:6), destained in the same that AD activity was present at high levels in L. brevis mixture without dye and dried. Sample collagenase (Figure 1a). The generation of citrulline by L. brevis Oral Diseases
  • 5. Anti-inflammatory effects of L. brevis DN Della Riccia et al 380 (a) Citrulline (pmol mg–1 prot min–1) (b) 45 40 35 30 25 20 15 665 bp 10 5 0 vis E e ne Markers AM n bre idi idi -N uan am L. +L orm nog +F mi +A (c) 5’ aaagaggttt ctagcgatgt cttcgatggc gtccgccgtc gtccgaggga aaccccaatt gctaagacgt gtcggacaa gacgagctcg tcgccccctt cgatgtggga ttcgtggttc cggtcgcgcc atacctcaac ttgccccgca aaccgtgggt ggtggttgat gatgtattcc gtgatcaggg Figure 1 Arginine deiminase expression in attcacgttg acgggccggg aaagtcatct tgttaatgga gatcccgtca Lactobacillus brevis extracts. (a) Arginine ccaatggagg cctgcggatc cgcgtgaag taagcgtttg gcattgggtc deiminase activity in bacterial extracts in the cattaagaac ggccagtccg tattttcgga aacggattgc agatccggtt presence or absence of formamidine, a specific gggcgatgtc aatgtcagtc ccccgcaccc cttcgatgat cttgtcaacc inhibitor of arginine deiminase, L-NMMA, a atttcctgcg gggtcatttg ggtagaggta gtcatataag gcgtcgtggg nitric oxide synthase (NOS) inhibitor, and tggtacccgc aacgtaacca gattcggcga tcatccgg 3’ aminoguanidine, a relatively specific inhibitor of the inducible form of NOS. The results represent the mean values of duplicate deter- (d) L. sakei L DMVEKIMAGVRT NEIDIKSK minations and are representative of one of L. brevis MET VDKI I EGVRGTDIDIAQP three experiments. SD values were ever lower than 10% of mean value. *P < 0.001 when L. sakei AL I DVSA - - - - - - - - - -- - - - compared with L. brevis extracts alone. (b) L. brevis DLQSVSENTDWPFLMETDPME Analysis of arginine deiminase gene, after L. sakei - - NLYFT RDPAASMGDGLTIN PCR amplification performed on genomic L. brevis TPNAYFTRDPQAS I GDGI SIN DNA, through 1.2% agarose gel electro- phoresis. (c) Analysis of the direct sequencing L. sakei KM - -TFEARQRESMFMEVIMQ of the PCR-obtained fragment amplimer L. brevis KMETTFPARQRESL I T EYI I N (arcA1-2). (d) The sequence of a 124 amino L. sakei HHPRFANQGAQVWRDRDH IDR acid residue encoded by the PCR-obtained L. brevis HHPRFAGO– VEVWRDRNHESH fragment, corresponding to arginine deimi- nase protein. The stringent homology (52%) L. sakei MEGGDEL ILSDKVLAIGIS L. brevis I EGGDELVLSDHVLAIGVS with the arginine deiminase of L. sakei is shown extract could be attributed to AD activity, as it was 124 amino acid residues which showed several conserved observed in the absence of NOS cofactors (NADPH, structural elements typical of AD genes. Comparing FAD, FMN, and BH4) and it was not affected either by amino acids residues of the AD of L. brevis and AD of L-valine, an arginase inhibitor, or by L-NMMA, a NOS L. sakei (Figure 1d), a stringent homology (52%) was inhibitor, and aminoguanidine, a relatively specific found. Although the AD gene is scarcely conserved, inhibitor of the inducible form of NOS. Moreover, the including the internal regions, our results clearly abrogation of citrulline generation observed in the demonstrated the presence of this gene in L. brevis. presence of formamidine, a specific inhibitor of AD, definitively established that the conversion of arginine to Clinical evaluation citrulline was due to the presence of high levels of this The scores for gingival inflammation, plaque, tartar, enzyme in L. brevis extracts. temperature sensitivity, and bleeding on probing before The presence of AD in L. brevis was further con- and after the treatment with L. brevis lozenges are firmed through the structural analysis of the gene reported in Table 1. All clinical parameters that were encoding the enzyme. A couple of primers designed on analyzed reached statistically significant differences the basis of consensus sequences known to be an between patients before treatment (T0) and the same internal region of the AD encoding gene was used to after treatment with L. brevis containing lozenges (T1). attempt PCR amplification. The PCR, performed on On the mean, gingival inflammation was rated as genomic DNA of L. brevis, yielded an amplimer of moderate/diffuse by 20 patients at enrollment, and mild 665 bp (Figure 1b) which was subjected to direct by one subject. After treatment, almost all patients sequencing. The sequencing of the PCR fragment, showed no gingival inflammation; two individuals named arcA1-2, resulted in a completely identified complained of a mild inflammation, while just one 478 bp sequence (Figure 1c) encoding a polypeptide of patient had a still moderate gingival inflammation. The Oral Diseases
  • 6. Anti-inflammatory effects of L. brevis DN Della Riccia et al 381 Table 1 Effect of the treatment with Lactobacillus brevis-containing HT1080 lozenges on gingival inflammation, plaque and calculus, temperature sensitivity, and bleeding in periodontitis patients Healthy controls T0 T1 P-value 250 Gingival inflammation 2.24 ± 0.12 0.14 ± 0.10 <0.0001 150 Plaque 2.10 ± 0.14 1.10 ± 0.12 <0.0001 92 100 Calculus 1.62 ± 0.21 1.29 ± 0.16 <0.0001 75 Temperature sensitivity 2.29 ± 0.14 0.43 ± 0.11 <0.0001 72 Bleeding 1.38 ± 0.19 0.05 ± 0.05 <0.0001 50 37 tolerability was considered as very good by all patients. Overall, the clinical evaluation of both the dentist and the patient overlapped, and the results confirmed recovery in 18 patients and improvement in three individuals. The antibiotic treatment for 4 days did 250 150 not significantly modify signs and symptoms (data not 92 100 shown), as expected. 75 72 Effects of L. brevis-containing lozenges on saliva sample 50 NOS activity, PGE2, IFN-c, and IgA levels 37 The levels of nitrites and nitrates and those of PGE2, IFN-c, and IgA, determined in the fluid saliva fraction of healthy controls and periodontitis patients, as described in Materials and methods in an unblinded HT1080 fashion, are reported in Table 2. Periodontitis patients’ saliva had a significantly higher level of nitrites/nitrates Patients when compared with normal subjects (P < 0.01). In the same Table are also reported the results obtained when Figure 2 Salivary matrix metalloproteinase (MMP) activity in healthy periodontitis patients’ saliva was analyzed for nitrite/ subjects and periodontitis patients. Gelatinase activity in the soluble nitrate levels before (T0) and after (T1) treatment with salivary fractions of representative healthy subjects and periodontitis L. brevis-containing lozenges. In all patients, the treat- patients is shown. The electrophoretic mobility of MMP-9 and MMP- 2, obtained from supernatants of HT1080 cell, is indicated on the left- ment was associated with a significant reduction in hand side. Molecular weights of the standard are indicated on the right nitrite and nitrate levels. Similar results were obtained when the conversion of radiolabeled arginine to citrul- line was analyzed in the cell saliva fraction (data not shown). In addition the PGE2 and IFN-c levels were amounts of MMPs than the control samples, thus significantly higher in patients with periodontitis than in confirming previous reports. Figure 2 shows gelatinase controls (P < 0.01). Interestingly, treatment with activity present in five different control salivary samples L. brevis-containing lozenges was associated with a (panel a) as well as in five different patients’ salivary strong decrease in the levels of these inflammation- samples (panel b), representative of all examined cases. associated molecules (P < 0.01). In contrast, IgA levels, Enzymatic activity was compared with that of gelatin- which were significantly reduced in patients compared ases obtained from the supernatants of the HT1080 cell with controls (P < 0.05), were not significantly mod- line stimulated with tissue plasminogen activator (TPA) ified by the treatment. (10)7 M) for 48 h (the 72 kDa type IV collagenase, gelatinase A, MMP-2, and the 92 kDa type IV collag- Effects of L. brevis-containing lozenges on saliva sample enase, gelatinase B, MMP-9). The zymogram of healthy MMP activity and levels control salivas (Figure 2a) shows bands with relative The measurements of MMP activity in the soluble molecular weights of 92 kDa, of about 120 kDa and fraction of saliva samples disclosed that the salivary higher than 200 kDa. Aside from a band of about samples of periodontitis patients contained higher 37 kDa, little or no enzymatic activity was visible at Table 2 Effect of the treatment with Lactobacillus brevis-containing lozenges on laboratory parameters in periodontitis patients Samples Nitrite/nitrate (lM) PGE2 (ng ml)1) IFN-c (pg ml)1) IgA (lg ml)1) HC 4.33 ± 1.31 P < 0.0001 0.32 ± 0.08 10.06 ± 0.84 885.62 ± 118.28 T0 38.86 ± 6.07* P < 0.0001 1.64 ± 0.1* 28.23 ± 2.11* 309.76 ± 143.06*P < 0.05 T1 9.39 ± 1.47** 0.46 ± 0.07** 8.82 ± 4.74**1.04 466.51 ± 237.1 HC, healthy controls; T0, before treatment; T1, after treatment. *P ¼ T0 vs HC; **P ¼ T1 vs T0. Oral Diseases
  • 7. Anti-inflammatory effects of L. brevis DN Della Riccia et al 382 molecular weights lower than 92 kDa. The profile of multiple forms of gelatinases found in patients’ saliva is shown in Figure 2b. In addition to the same bands of 250 controls, a strong gelatinolytic activity at molecular 150 weights lower than 92 kDa could be seen in all patients’ salivas. In some cases (i.e., lanes 2 and 3) the high 100 molecular weight activities of gelatinase were almost 75 absent, being prevailing below 92 kDa. These latter species mainly migrated with a connecting smear, being evident as separate bands only at the 37–50 kDa region. 50 The gelatinolytic activity detected by zimogram appeared to be due to the presence of MMPs, as protease activity was completely abrogated by the C T0 T1 T0 T1 T0 T1 addition of EDTA, but not by the addition of serine Patient n. 4 5 6 and cysteine proteinase inhibitors to the incubation buffer (data not shown). The treatment with lozenges led Figure 4 Effects of Lactobacillus brevis-containing lozenges on saliva sample matrix metalloproteinase levels. Western blot analysis of to the near disappearance of these MMP bands in all gelatinase expression in one representative healthy control and three patients’ samples. Figure 3 shows the gelatinolytic activ- periodontitis patients’ saliva samples before and after treatment with ity of five representative periodontitis patients before lozenges containing L. brevis. C, healthy control; T0, before treatment; (T0) and after (T1) the treatment with experimental T1, after treatment. Molecular mass markers are indicated on the left- hand side lozenges. The profile of multiple forms of gelatinases was similar in all patients. The treatment led to the near disappearance of the low molecular weight bands and 92 kDa were detected. Western blotting with specific restored the control profile of gelatinolytic activity. antibodies against human MMP-2, MMP-3, MMP-1, Western blot experiments demonstrated that the bands and MMP-8 showed no immunoreactivity, suggesting revealed by zymograms were due mainly to the enzymatic that these MMPs were not detectable in the saliva of either activity of MMP-9. Figure 4 shows a Western blot of one controls or patients (data not shown). representative control and three representative patients before and after treatment with experimental lozenges. In Effect of L. brevis extracts on macrophage NOS activity the saliva of patients antibody against MMP-9 revealed Rat peritoneal macrophages incubated in vitro in the some high molecular weight forms (>200 kDa) together presence of LPS for 18 h were induced to express iNOS with bands at the 180 kDa region and at 120 kDa. Other activity (Figure 5a). NOS activity was inhibited by the molecular weights ranging from 92 to 64 kDa and NOS inhibitors AG and L-NMMA. In the presence of approximately at 54 and 44 kDa were seen in the saliva bacterial extracts, NOS activity disappeared and argin- of patients with chronic periodontitis. After treatment the ine was converted in citrulline through bacterial AD, enzymatic pattern resembled that of healthy controls. as demonstrated either by the unsensitivity of this Indeed, a relevant reduction in high molecular weight conversion to NOS inhibitor treatment (Figure 5a) or bands was observed and little or no MMP-9 species below by the disappearance of enzymatic activity in the presence of the AD inhibitor, formamidine (data not shown). Similar results were obtained with L. fermentum 250 extracts, but not with Streptococcus thermophilus, a 150 LAB in which the AD activity was not detectable (not 100 shown). 92 75 These results suggest that bacterial AD was able to 72 50 totally utilize the arginine present in the medium thus 37 preventing its uptake by macrophages and consequently NOS activity. Effect of L. brevis extracts on macrophage PGE2 release When rat peritoneal macrophages were cultured for up HT1080 T0 T1 T0 T1 T0 T1 T0 T1 T0 T1 to 18 h with LPS, a gradual accumulation of PGE2 in the supernatants occurred (fivefold increase over that in 4 5 7 3 6 control cells) (Figure 5b). This effect was almost totally Patient n. abrogated in the presence of L. brevis extracts as Figure 3 Effects of Lactobacillus brevis-containing lozenges on saliva occurred when the cells were previously treated with sample matrix metalloproteinase (MMP) activity. Zymography com- L-NMMA or aminoguanidine. paring gelatinolitic activities in saliva of five periodontitis patients before treatment (T0) with gelatinolitic activities in saliva of the same Effect of L. brevis extracts on MMP production by patients after treatment with L. brevis-containing lozenges (T1). The electrophoretic mobility of MMP-9 and MMP-2, obtained from macrophages in the presence of LPS supernatants of HT1080 cell line, is indicated on the left-hand side. To investigate the L. brevis effect on MMP production, Molecular weights of the standard are indicated on the right-hand side activated rat peritoneal macrophages were treated with Oral Diseases
  • 8. Anti-inflammatory effects of L. brevis DN Della Riccia et al 383 (a) 3 Control L. brevis Citrulline (pmol mg–1 prot min–1) 2.5 LPS LPS + L. brevis 2 1.5 1 0.5 0 None L-NAME Aminoguanidine Formamidine LPS + L. brevis (b) 60 Control (c) L. brevis LPS PGE2 (ng/106 cells) 50 HT 1080 LPS+ L.brevis L. brevis Control Figure 5 Effect of Lactobacillus brevis LPS+ L-NMMA LPS+ AG LPS extracts on LPS-activated macrophages. 40 Effect of L. brevis extracts on iNOS activity (a), PGE2 levels (b) and MMP activity (c) in 30 rat peritoneal macrophages incubated in vitro MMP9 in the presence or absence of LPS for 18 h. 20 Where indicated, the effect of L-NMMA, 10 MMP2 aminoguanidine (AG), and formamidine is shown 0 bacterial extracts in the presence or absence of LPS and enzymatic activity (Di Marzio et al, 2001), we checked cell culture supernatants were analyzed by zymography the presence of the AD gene. The analysis of a fragment for MMP-9 and MMP-2 levels. Compared with macr- obtained by PCR unambiguously revealed the presence ophages in culture medium alone, LPS increased MMP- of this gene, thus confirming our previous findings. 9 activity, whereas MMP-2 was not detectable. The Nitric oxide is known to be an important inflamma- presence of L. brevis extract in the culture medium led to tory mediator, and is involved in the pathophysiology of a relevant decrease in MMP-9 activity, either when several inflammatory disorders. An increase in NO added alone or in the presence of stimuli. Similarly, a production has been also demonstrated in periodontitis total inhibition of MMP activity was observed in the as its role in the inflammatory response of periodontal presence of iNOS inhibitors. A representative zymogra- tissues has been suggested (Matejka et al, 1998, 1999; phy is illustrated in Figure 5c. Enzymatic activity was Lappin et al, 2000; Hirose et al, 2001; Kendall et al, compared with that of partially purified gelatinases 2001; Lohinai et al, 2001; Daghigh et al, 2002). These (MMP-2 and MMP-9) obtained from the supernatants findings are consistent with the hypothesis suggesting of HT1080 cell line stimulated with TPA (10)7M) for that treatment with agents able to block the production 48 h. The bands revealed by zymograms could be of NO or its effects might be therapeutically valuable for attributed to MMPs as they disappear with EDTA but periapical lesions (Lohinai et al, 1998; Paquette and not by the addition of other proteinase inhibitors to the Williams, 2000; Daghigh et al, 2002). Considering the incubation buffer (data not shown). role of NO in inflammatory events in general and in periodontitis in particular, we analyzed the potential beneficial effects of L. brevis-based treatment in patients Discussion with periodontal disease. Of note, the proposed experi- Periodontitis is characterized by extensive destruction of mental treatment led to the total disappearance or the gingival tissues and associated supporting structures amelioration of all analyzed clinical parameters (gingi- of the teeth. In the present work, we first analyzed the val inflammation, plaque, calculus, temperature sensi- potential anti-inflammatory action in vivo of L. brevis- tivity, and bleeding on probing) in almost all 21 patients containing lozenges in 21 adult patients with periodontal (recovery in 18 patients and improvement in three disease. Previously, our group reported the presence of individuals). The beneficial effects of the treatment on arginine-deiminase in L. brevis, a strain belonging to clinical signs and symptoms were paralleled by a strong LAB (Di Marzio et al, 2001). The presence of high levels and statistically significant decrease in oral NOS activ- of this enzyme, which metabolize arginine to citrulline ity. Besides its direct role as an inflammatory modulator, and ammonia, aids L. brevis extracts to inhibit NO NO represents a multifunctional messenger molecule generation, by competing with NOS for the same able to modulate the production of inflammatory substrate, arginine. To confirm the presence of AD in cytokines (Cifone et al, 1999), PGE2 (Goodwin et al, L. brevis, previously shown through the assay of 1999), and MMPs (Maeda et al, 1998; Tronc et al, 2000; Oral Diseases
  • 9. Anti-inflammatory effects of L. brevis DN Della Riccia et al 384 Hirai et al, 2001). On the other hand, inflammatory exclude the possibility that L. brevis extract-based cytokines such as IFN-c, tumor necrosis factor-a and treatment, besides the anti-inflammatory effects repor- interleukin-1-a have been shown to be significantly ted here, is also able to antagonize the growth of specific higher in periodontitis patients than in healthy controls periodontopathic pathogens. (Takeichi et al, 2000; Hirose et al, 2001; Tervahartiala Taken together, our findings give further insights into et al, 2001; Ukai et al, 2001). Moreover, the generation the knowledge of the molecular basis of periodontitis of PGE2, a potent eicosanoid lipid mediator derived and have a potential clinical significance, representing from phospholipase-released arachidonic acid that is the experimental ground for a new innovative, simple involved in numerous homeostatic biologic functions and efficacious therapeutical approach of periodontal and inflammation, has been shown to be strongly disease. incremented in periodontal lesions (Cavanaugh et al, 1998; Leibur et al, 1999; Paquette and Williams, 2000; Acknowledgements Tsilingaridis et al, 2003). Furthermore, MMP levels have been previously shown to play a critical role in the The authors thank Gasperina De Nuntiis (Department of inflammatory process leading to alveolar bone and Experimental Medicine, University of L’Aquila, L’Aquila, connective tissue loss in periodontal disease (Makela Italy) for technical assistance and Miss Florence Pryen for et al, 1994; Ding et al, 1995; Ejeil et al, 2003; Sorsa et al, careful language revision of the manuscript. This work was 2004). Indeed, one of the most salient features of financially supported by grant ÔPROGETTO DI INTERESSE GENERALE DI ATENEO’ from the University of L’Aquila. periodontitis and gingivitis is the increase in the levels of bacterial and host-derived proteolytic enzymes in oral inflammatory exudates. Bacterial pathogens involved in References periodontal diseases partly trigger and induce host cells Baron AC, Gansky SA, Ryder MI et al (1999). Cysteine to elevate their secretion of MMP. Proteolytic enzymes protease inhibitory activity and levels of salivary cystatins in released by the host cells and/or by pathogen bacteria whole saliva of periodontally diseased patients. J Periodon- are associated with tissue destruction and MMP have tal Res 34: 437–444. the primary role in this process as they can degrade most Bodana AR, Rao DR (1990). Antimutagenic activity of milk of the extracellular matrix components (Ding et al, fermented by Streptococcus thermophilus and Lactobacillus 1995). bulgaricus. J Dairy Sci 73: 3379–3384. Altogether, these observations prompted us to ana- Caglar E, Kargul B, Tanboga I (2005). Bacteriotherapy and ¸ lyze the potential effects of L. brevis extracts containing probiotics’ role on oral health. Oral Dis 11: 131–137. lozenges on IFN-c, PGE2, and MMP salivary levels in Cavanaugh PFJR, Meredith MP, Buchanan W et al (1998). Coordinate production of PGE2 and IL-1 beta in the periodontitis patients. Our findings clearly showed that gingival crevicular fluid of adults with periodontitis: its all these inflammatory-associated factors were drastic- relationship to alveolar bone loss and disruption by twice ally reduced in periodontal disease patients after the daily treatment with ketorolac tromethamine oral rinse. L. brevis-based treatment. However, no significant J Periodontal Res 33: 75–82. effects were observed on salivary IgA levels after the ` Cifone MG, D’alo S, Parroni R et al (1999). Interleukin-2- proposed treatment. activated rat natural killer cells express inducible nitric oxide In the attempt to define the mechanisms underlying synthase that contributes to cytotoxic function and inter- the anti-inflammatory action of L-brevis-based treat- feron-gamma production. Blood 93: 3876–3884. ment, a set of experiments were performed by using rat Daghigh F, Borghaei RC, Thornton RD et al (2002). Human peritoneal macrophages activated in vitro with LPS in gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 73: 392–400. the presence or absence of bacterial extracts. The results Di Marzio L, Russo PF, Biordi L et al (2001). Apoptotic indicated that the LPS-induced iNOS activity, PGE2 effects of selected strains of lactic acid bacteria on a human generation, and MMP activation were almost totally T leukaemia cell line are associated with bacterial arginine abrogated when macrophages were cultured in the deiminase and/or sphingomyelinase activities. Nutr Cancer presence of bacterial extracts, thus strongly supporting 40: 185–196. the in vivo observations. The finding that iNOS inhib- Ding Y, Uitto VJ, Firth J et al (1995). Modulation of host itors were able to inhibit either PGE2 release or MMP matrix metalloproteinases by bacterial virulence factors activity in LPS-activated macrophages, prompted us to relevant in human periodontal diseases. Oral Dis 1: 279–286. hypothesize that NO could be responsible for the latter Dugas B, Mercenier A, Lenoir-Wijnkoop I et al (1999). events, as previously reported in several systems (Maeda Immunity and probiotics. Immunol Today 20: 387–390. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S et al (2003). et al, 1998; Goodwin et al, 1999; Tronc et al, 2000; Expression of matrix metalloproteinases (MMPs) and tissue Hirai et al, 2001). The anti-inflammatory effects of inhibitors of metalloproteinases (TIMPs) in healthy and L. brevis extracts could thus be attributed to their diseased human gingiva. J Periodontol 2: 188–195. ability to prevent iNOS activity and, consequently Golub LM, Ryan ME, Williams RC (1998). Modulation of the NO-dependent PGE2 release and MMP activation. host response in the treatment of periodontitis. Dent Today Considering recent reports showing that Lactobacillus 17: 102–106. and Bifidobacterium spp. or their components protected Goodwin DC, Landino LM, Marnett LJ (1999). Effects of the host against certain oral diseases by inhibiting the nitric oxide and nitric oxide-derived species on prostaglan- growth of potential pathogens (Smith et al, 2001; din endoperoxide synthase and prostaglandin biosynthesis. Grudianov et al, 2002; Volozhin et al, 2004), we cannot FASEB J 13: 1121–1136. Oral Diseases
  • 10. Anti-inflammatory effects of L. brevis DN Della Riccia et al 385 Gorbach SL (2000). Probiotics and gastrointestinal health. Am McGee JM, Tucci MA, Edmundson TP et al (1998). The J Gastroenterol 95 (Suppl. 1): S2–S4. relationship between concentrations of proinflammatory Graves DT (1999). The potential role of chemokines and cytokines within gingival and the adjacent sulcural depth. inflammatory cytokines in periodontal disease progression. J Periodontol 69: 865–871. Clin Infect Dis 28: 482–490. Offenbacher S (1996). Periodontal diseases: pathogenesis. Ann Grudianov AI, Dmitrieva NA, Fomenko EV (2002). Use of Periodontol 1: 821–878. probiotics Bifidumbacterin and Acilact in tablets in therapy Paquette DW, Williams RC (2000). Modulation of host of periodontal inflammation. Stomatologiia Mosk 81: 39–43. inflammatory mediators as a treatment strategy for perio- Henskens YM, Van Den Keijbus PA, Veeman EC et al (1996). dontal diseases. Periodontol 2000 24: 239–252. Protein composition of whole and parotid saliva in healthy Roberfroid MB (1998). Prebiotics and synbiotics: concepts and and periodontitis subjects. Determination of cystatins, nutritional properties. Br J Nutr 80: S197–S220. albumin, amylase and IgA. J Periodontol Res 31: 57–65. Schenk K, Poppelsdorf D, Denis C et al (1993). Levels of Hirai Y, Migita K, Honda S et al (2001). Effects of nitric oxide salivary IgA antibodies reactive with bacteria from dental on matrix metalloproteinase-2 production by rheumatoid plaque are associated with susceptibility to experimental synovial cells. Life Sci 68: 913–920. gingivitis. J Clin Periodontol 20: 411–417. Hirose M, Ishihara K, Saito A et al (2001). Expression of Silness J, Loe H (1964). Periodontal disease in pregnancy. II. ¨ cytokines and inducible nitric oxide synthase inflamed Correlation between oral hygiene and periodontal condi- gingival tissue. J Periodontol 72: 590–597. tion. Acta Odontol Scand 22: 121–135. Ishii Y, Ogura T, Tatemichi M et al (2003). Induction of Smith SI, Aweh AJ, Coker AO et al (2001). Lactobacilli in matrix metalloproteinase gene transcription by nitric oxide human dental caries and saliva. Microbios 105: 77–85. and mechanisms of MMP-1 gene induction in human Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloprotein- melanoma cell lines. Int J Cancer 103: 161–168. ases (MMPs) in oral diseases. Oral Dis 6: 311–318 (Review). Kendall HK, Marshall RI, Bartold PM (2001). Nitric oxide Takeichi O, Haber J, Kawai T et al (2000). Cytokine profiles and tissue destruction. Oral Dis 7: 2–10. of T-lymphocytes from gingival tissues with pathological Konings WN, Kok J, Kuipers OP et al (2000). Lactic acid pocketing. J Dent Res 79: 1548–1555. bacteria: the bugs of the new millennium. Curr Opin Tervahartiala T, Koski H, Xu JW et al (2001). Tumor necrosis Microbiol 3: 276–282. factor-alpha and its receptors, p55 and p75, in gingiva of Kornman KS (1999). Host modulation as a therapeutic adult periodontitis. J Dent Res 80: 1684–1687. strategy in the treatment of periodontal disease. Clin Infect Thorgeirsson UP, MacKay AR (1992). Characterization of Dis 28: 520–526. metastatic tumor cell. In: Gallegner CT, Rees RC, Reynolds Korostoff JM, Wang JF, Sarment DP et al (2000). Analysis of CW, eds. Tumor immunology: a practical approach. Univer- in situ protease activity in chronic adult periodontitis sity Press: Oxford, pp. 82–90. patients: expression of activated MMP-2 and a 40 kDa Travis J, Potemba J (2000). Bacterial proteinases as targets for serine protease. J Periodontol 71: 353–360 the development of second-generation antibiotics. Biochim Lappin DF, Kjeldsen M, Sander L et al (2000). Inducible nitric Biophys Acta 1477: 35–50. oxide synthase expression in periodontitis. J Periodontal Res Tronc F, Mallat Z, Lehoux S et al (2000). Role of matrix 35: 369–373. metalloproteinases in blood flow-induced arterial enlarge- Leibur E, Tuhkanen A, Pintson U et al (1999). Prostaglandin ment: interaction with NO. Arterioscler Thromb Vasc Biol E2 levels in blood plasma and in crevicular fluid of advanced 20: E120–E126. periodontitis patients before and after surgical therapy. Oral Tsai CC, Hong CC, Chen CC et al (1998). Measurement of Dis 5: 223–228. prostaglandin E2 and leukotriene B4 in the gingival crevic- Lohinai Z, Benedek P, Feher E et al (1998). Protective effects ular fluid. J Dent 26: 97–103. of mercaptoethylguanidine, a selective inhibitor of inducible Tsilingaridis G, Yucel-Lindberg T, Modeer T (2003). Enhanced nitric oxide synthase, in ligature-induced periodontitis in the levels of prostaglandin E2, leukotriene B4, and matrix rat. Br J Pharmacol 123: 353–357. metalloproteinase-9 in gingival crevicular fluid from patients Lohinai Z, Stachlewitz R, Virag L et al (2001). Evidence for with Down syndrome. Acta Odontol Scand 3: 154–158. reactive nitrogen species formation in the gingivomucosal Ukai T, Mori Y, Onoyama M et al (2001). Immunohistolog- tissue. J Dental Res 80: 470–475. ical study of interferon-gamma- and interleukin-4-bearing Maeda H, Okamoto T, Akaike T (1998). Human matrix cells in human periodontitis gingival. Arch Oral Biol 46: metalloproteinase activation by insults of bacterial infection 901–908. involving proteases and free radicals. Biol Chem 379: Volozhin AI, Il’in VK, Maksimovskii IuM et al (2004). 193–200. Development and use of periodontal dressing of collagen Makela M, Salo T, Uitto VJ et al (1994). Matrix metallopro- and Lactobacillus casei 37 cell suspension in combined teinases (MMP-2 and MMP-9) of the oral cavity: cellular treatment of periodontal disease of inflammatory origin (a origin and relationship to periodontal status. J Dental Res microbiological study). Stomatologiia (Mosk) 83: 6–8 73: 1397–1406. Weikmann JL, Himmel ME, Smith DW et al (1978a). Argin- Matejka M, Partyka L, Ulm C et al (1998). Nitric oxide ine deiminase: demonstration of two active sites and possible synthesis is increased in periodontal disease. J Periodontal half-of-the-sites reactivity. Biochem Biophys Res Commun Res 33: 517–518. 83: 107–113. Matejka M, Ulm C, Partyka L et al (1999). Nitric oxide Weikmann L, Himmel ME, Squire PG et al (1978b). Arginine synthesis is increased in periodontitis. Adv Exp Med Biol deiminase from Mycoplasma arthritidis. Properties of the 469: 419–424. enzyme from log phase cultures. J Biol Chem 253: 6010–6015. Oral Diseases